[go: up one dir, main page]

WO2020235459A1 - Liquid oil-in-water composition - Google Patents

Liquid oil-in-water composition Download PDF

Info

Publication number
WO2020235459A1
WO2020235459A1 PCT/JP2020/019369 JP2020019369W WO2020235459A1 WO 2020235459 A1 WO2020235459 A1 WO 2020235459A1 JP 2020019369 W JP2020019369 W JP 2020019369W WO 2020235459 A1 WO2020235459 A1 WO 2020235459A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
component
liquid
emulsified
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2020/019369
Other languages
French (fr)
Japanese (ja)
Inventor
茜 阿部
はるな 早▲瀬▼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Priority to KR1020217037463A priority Critical patent/KR20220009958A/en
Priority to JP2021520756A priority patent/JP7585198B2/en
Priority to CN202080036679.3A priority patent/CN113811283B/en
Publication of WO2020235459A1 publication Critical patent/WO2020235459A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to a liquid oil-in-water composition, and more particularly to a liquid oil-in-water composition which is liquid but has excellent viscosity stability and emulsion stability over time.
  • Patent Document 2 such as a technique for inducing ⁇ -gel formation by adding warm oil to this composition, then adding water and stirring (Patent Document 2), to improve emulsion stability by using ⁇ -gel. Attempts have been made to achieve this.
  • ⁇ -gel is one of the self-assembling bodies formed by amphipathic substances. It is located between the solid hydrated crystal (core gel) and the lamellar liquid crystal, and a large amount of water is allowed between the hydrophilic groups while maintaining the crystalline state. It is in a held state. Crystals that can hardly hold water, such as core gel, are in a state where the molecules themselves are tilted and packed more densely, whereas in lamellar liquid crystal, the structure of the bilayer liquid crystal is rich in fluidity and is in a liquid state, so many Can hold water.
  • ⁇ -gel Similar to lamellar liquid crystal, ⁇ -gel has surfactants arranged in layers, but since it is regularly packed in hexagonal crystals, it retains rotational motion, but it has less hydrophobic group mobility than lamellar liquid crystal. , The movement of molecules is controlled. When the difference in motility based on such a structure is observed by differential scanning calorimetry (DSC) or the like, heat transfer can be observed as a gel-liquid crystal phase transition.
  • DSC differential scanning calorimetry
  • the ⁇ -gel is an intermediate phase between the lamellar liquid crystal and the core gel, it is usually unstable, and the viscosity of the ⁇ -gel-containing oil-in-water emulsified composition obtained by the techniques of Patent Documents 1 and 2 also increases with time. In some cases, the viscosity stability was lacking. Further, the techniques of Patent Documents 1 and 2 impart emulsification stability based on the thickening action of ⁇ -gel, and since the viscosity becomes relatively high immediately after production, it is applicable to liquid cosmetics such as lotion. It was difficult to apply the technology.
  • An object of the present invention is to provide an oil-in-water emulsification composition which is liquid but has excellent viscosity stability and emulsion stability over time.
  • the present inventors have specified specific N-stearoyl-N-methyltaurine sodium or N-stearoyl-L-glutamic acid and salts thereof with respect to the linear saturated higher alcohol.
  • the particle size of the emulsified droplets formed is 160 nm or less after combining an anionic surfactant in a predetermined amount, the liquid properties are maintained for a long period of time after production without thickening over time.
  • they have found that a good emulsified state can be stably maintained without causing creaming or separation, and have completed the present invention.
  • the present invention describes the following components (A) to (C); (A) Linear saturated higher alcohol having 16 or more carbon atoms (B) One or more anionic ones selected from the group consisting of N-stearoyl-N-methyltaurine sodium and N-stearoyl-L-glutamic acid and salts thereof.
  • Surfactant (C) Contains liquid oil, the molar ratio (A / B) of the component (A) to the component (B) is 2.8 to 6, and the components (A) and (B) to the component (C).
  • a liquid oil-in-water composition having a total mass ratio ((A + B) / C) of 0.3 to 0.75 and an average emulsified particle size of 160 nm or less.
  • the oil-in-water emulsified composition of the present invention is liquid but excellent in viscosity stability and emulsion stability over time, retains liquid properties without thickening for a long period of time, and is creamed and separated. It is possible to stably maintain a good emulsified state without causing such problems. Further, when the oil-soluble active ingredient is contained in the composition, the stability over time can be improved, and the action and effect based on the active ingredient can be stably maintained.
  • linear saturated higher alcohol having 16 or more carbon atoms examples include cetyl alcohol, cetostearyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol, lignoceryl alcohol, and ceryl alcohol, and one of them. Alternatively, two or more types can be used. Among these, from the viewpoint of viscosity stability and emulsion stability, setostearyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol and the like are preferable, and setostearyl alcohol and stearyl alcohol are particularly preferable.
  • composition The content of the component (A) in the oil-in-water composition of the present invention (hereinafter, may be simply referred to as “composition”) is 0.5 to 2% by mass (from the viewpoint of viscosity stability and emulsion stability). Hereinafter, it is preferably simply referred to as “%”), and more preferably 1 to 1.7%.
  • the component (B) is N-stearoyl-N-methyltaurine sodium, N-stearoyl-L-glutamic acid and a salt thereof, which are anionic surfactants, and the N-stearoyl-L-glutamic acid salt is a sodium salt.
  • examples thereof include potassium salts and magnesium salts, and one or more of these can be used.
  • N-stearoyl-N-methyltaurine sodium, N-stearoyl-L-glutamic acid, and N-stearoyl-L-glutamic acid disodium are preferable from the viewpoint of viscosity stability and emulsion stability.
  • the content of the component (B) in the composition of the present invention is preferably 0.4 to 1%, more preferably 0.5 to 0.9% from the viewpoint of viscosity stability and emulsion stability.
  • the liquid oil of component (C) can be used without particular limitation as long as it is liquid at room temperature (25 ° C.).
  • isododecane isohexadecane, light isoparaffin, liquid paraffin (mineral oil), squalane, squalane, ⁇ -.
  • Hydrocarbons such as olefin oligomer, polybutene, liquid isoparaffin, heavy liquid isoparaffin, polyisobutylene, hydrogenated polyisobutene; abrana seed oil, avocado oil, almond oil, apricot kernel oil, egoma oil, orange oil, olive oil, kiwi seed oil , Sesame oil, wheat germ oil, rice germ oil, rice bran oil, safflower oil, sage oil, soybean oil, tea seed oil, corn oil, rapeseed oil, evening primrose oil, camellia oil, persic oil, honeybee oil, peanut oil, sunflower Animal and vegetable oils such as oils, grape seed oils, meadowfoam oils, rosemary oils, jojoba oils, macadamia nut oils, lavender oils, rosehip oils, mink oils; Cetyl 2-ethylhexanoate, isopropyl myristate, isopropyl palmitate, -2-ethylhexyl palmitate
  • non-polar oil is preferable from the viewpoint of viscosity stability and emulsion stability, and for example, isododecane, isohexadecane, light isoparaffin, liquid paraffin (mineral oil), squalane, squalane, ⁇ -olefin oligomer, polybutene, and liquid isoparaffin.
  • Heavy fluid isoparaffin polyisobutylene, hydrogenated polyisobutene and other hydrocarbons, dimethylpolysiloxane (dimethicone), methyltrimethicone, methylphenylpolysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, tetramethyltetrahydro Gencyclotetrasiloxane, tetramethyltetraphenylcyclotetrasiloxane, tetramethyltetratrifluoropropylcyclotetrasiloxane, pentamethylpentatrifluoropropylcyclopentasiloxane, polyether-modified methylpolysiloxane, oleyl-modified methylpolysiloxane, polyvinylpyrrolidone-modified methyl Examples thereof include silicone oils such as polysiloxane, and one or more of these can be
  • liquid paraffin mineral oil
  • dimethylpolysiloxane dimethylpolysiloxane
  • the content of the component (C) in the composition of the present invention is preferably 1 to 10%, more preferably 1.5 to 6.5% from the viewpoint of viscosity stability and emulsion stability.
  • the mass ratio of polar oil to non-polar oil ((polar oil) / (non-polar oil)) is preferably 0.5 or less from the viewpoint of improving the oil-soluble active ingredient and the stability of viscosity and emulsification. , 0.3 or less is more preferable.
  • the liquid oil of the component (C) does not include the oil-soluble active ingredient of the component (D) described later.
  • the polar oil used in the present invention preferably has an IOB (Inorganic-Organic balance) of 0.05 to 0.8, more preferably 0.05 to 0.6, from the viewpoint of viscosity stability and emulsion stability. Is even more preferable.
  • the IOB of the non-polar oil used in the present invention is preferably less than 0.05, more preferably 0.03 or less, from the viewpoint of viscosity stability and emulsion stability.
  • the IOB in the present invention is calculated by the following (Equation 1).
  • IOB ( ⁇ inorganic value / ⁇ organic) ...
  • Equation 1 That is, the IOB is based on the "inorganic value” and “organic value” set for each of various atoms and functional groups, and the "inorganic value” of the atoms and functional groups constituting the organic compound such as a surfactant.
  • Organic value can be calculated by integrating (see Yoshio Koda, "Organic Conceptual Diagram-Basics and Applications-", pp. 11-17, Sankyo Publishing, 1984).
  • the mixed IOB of the liquid oil is preferably 0.8 or less, more preferably 0.6 or less, and further preferably 0.4 or less. It is more preferably 0.2 or less, and particularly preferably 0.2 or less.
  • the mixed IOB (IOB total ) of N kinds of liquid oils is calculated by the following (Equation 2).
  • IBO total IOB 1 ⁇ W 1 + IOB 2 ⁇ W 2 + ⁇ ⁇ ⁇ IOB N ⁇ W N ...
  • the molar ratio (A / B) of the component (A) to the component (B) is 2.8 to 6 from the viewpoint of viscosity stability and emulsion stability. Is preferable, and 2.8 to 4 is more preferable.
  • the total mass ratio of the components (A) and (B) to the component (C) ((A + B) / C)) is 0.3 to 0.75 from the viewpoint of viscosity stability and emulsion stability. It is preferably 0.3 to 0.72, and more preferably 0.3 to 0.72.
  • the water content in the composition of the present invention is preferably 70 to 85%, more preferably 75 to 80%, from the viewpoint of viscosity stability and emulsion stability.
  • An aqueous solvent can be used in addition to water for the composition of the present invention.
  • the aqueous solvent include lower alcohols such as ethyl alcohol and propyl alcohol, glycols such as propylene glycol, 1,3-butylene glycol, dipropylene glycol, 1,2-pentanediol and polyethylene glycol, glycerin and diglycerin. , Glycerols such as polyglycerin, and the like, and one or more of these can be used.
  • 1,3-butylene glycol, dipropylene glycol, glycerin, diglycerin, and polyglycerin are preferable from the viewpoint of viscosity stability and emulsion stability.
  • the mass ratio of the aqueous solvent to water is preferably 5 to 20, more preferably 6 to 15, from the viewpoint of viscosity stability and emulsion stability.
  • composition of the present invention can further contain the component (D) oil-soluble active ingredient.
  • Oil-soluble active ingredients include tocopherol, carotenoid, retinol, ceramide and glycyrrhetinic acid and esters thereof; oil-soluble licorice, oil-soluble yokuinin extract, oil-soluble rosemary extract, ubidecalenone and the like, and one or two of them. The above can be used.
  • the component (D) one or more selected from the group consisting of carotenoids and esters thereof is preferable.
  • Carotenoids include actinioerythrol, astaxanthin, bixin, cantaxanthin, capsantin, capsorbin, ⁇ -8'-apo-carotene (apocarotenal), ⁇ -12'-apo-carotene, ⁇ -carotene, ⁇ -carotene, " Carotene "(mixture of ⁇ - and ⁇ -carotene), ⁇ -carotene, ⁇ -carotene, ⁇ -cryptoxanthin, ekinenone, palm oil carotene, rutin, lycopene, biorelitrin, zeaxanthin, fucoxanthin, anteraxanthin, violaxanthin, etc.
  • the carotenoid ester examples include an ester in which a carotenoid containing a hydroxyl group or a carboxyl group and a fatty acid or a fatty alcohol form one or more ester bonds.
  • the component (D) one or more selected from the group consisting of astaxanthin and this ester is preferable.
  • the fatty acid or fatty alcohol forming the ester is preferably one having a saturated or unsaturated hydrocarbon chain having a straight chain or a branched chain having 8 to 24 carbon atoms.
  • the content of the component (D) in the composition of the present invention is appropriately set depending on the type of the oil-soluble active ingredient, and is preferably 0.00001 to 1%, more preferably 0.00001 to 0.5, for example.
  • any component can be used in the composition of the present invention as long as it does not impair the effects of the present invention.
  • the optional component include solid oil, powder, ultraviolet scattering agent, preservative, fragrance and the like.
  • the composition of the present invention can be prepared by emulsifying and mixing the above-mentioned essential components and optional components to be blended as necessary according to a known method.
  • the oil phase containing the components (A) to (C) and the aqueous phase containing water are respectively heated and dissolved, the oil phase is added to the aqueous phase, emulsified and mixed using a dispersion or the like, and then micron.
  • the oil-in-water composition of the present invention is prepared by high-pressure emulsification treatment using a fluidizer, an ultimateizer, a nano perenniala or the like.
  • the average emulsified particle size of the oil-in-water composition of the present invention is 160 nm or less, preferably 60 to 130 nm, and more preferably 70 to 120 nm from the viewpoint of viscosity stability and emulsification stability.
  • the average emulsified particle size can be adjusted by adjusting the pressure in the high-pressure emulsification treatment, the treatment time, the number of treatments, and the like.
  • the average emulsified particle size is a value measured by the method described in Examples.
  • the oil-in-water composition of the present invention becomes excellent in viscosity stability over time while being liquid, and the reason is as follows. Conceivable. That is, in the process of producing the oil-in-water composition of the present invention, when ⁇ -gel is formed from the components (A) and (B), if the particle size of the emulsified droplet is large, a part of the ⁇ -gel is of the emulsified droplet. It exists in the surroundings and covers the emulsified droplets, but the other ⁇ -gels are dispersed in the continuous phase.
  • the ⁇ -gel film structure that covers the emulsified droplets is not formed even if the average emulsified particle size is 160 nm or less. Therefore, the viscosity increases with time.
  • ⁇ -gel film structure an ⁇ -gel film structure that covers such emulsified droplets.
  • DSC differential scanning calorimetry
  • this heat absorption peak gradually shrinks, and another heat absorption peak based on the ⁇ -gel film structure that coats the emulsified droplet on the lower temperature side is observed.
  • two endothermic peaks based on the excess ⁇ -gel and ⁇ -gel membrane structure are observed in the range of 58 to 68 ° C., or only one endothermic peak based on the ⁇ -gel membrane structure on the lower temperature side is observed. If is observed, the presence of an ⁇ -gel membrane structure covering the emulsified droplets is recognized.
  • the presence of such an ⁇ -gel film structure that covers the emulsified droplets is considered to contribute to the improvement of the stability of the oil-soluble active ingredient. That is, when the oil-in-water emulsified composition contains an oil-soluble active ingredient, the oil-soluble active ingredient is mainly present in the emulsified droplet, but does not always stay in the same place and is a molecule to the aqueous phase which is a continuous phase. Diffusion has occurred (Ostwald ripening, see Non-Patent Document 3), and the oil-soluble active ingredient comes into contact with continuous-phase water or the like, causing deterioration of the oil-soluble active ingredient.
  • the presence of the ⁇ -gel film structure that covers the emulsified droplets makes the emulsified droplet interface stronger, so that the contact of the oil-soluble active ingredient with water or the like due to the Ostwald drying is suppressed, and as a result, the contact with water or the like is suppressed. It is presumed that the stability of the oil-soluble active ingredient over time is improved.
  • the endothermic peak based on the excess ⁇ -gel on the higher temperature side (60 ° C or higher and 68 ° C or lower) and the lower temperature side (58 ° C or higher and lower than 60 ° C) are in the range of 58 ° C to 68 ° C. It may include one or both peaks of endothermic peaks based on the ⁇ -gel membrane structure that coats the emulsified droplets of.
  • Q 0 is the amount of heat (J / g) obtained from the total area of the endothermic peak included in the temperature range of 58 ° C to 68 ° C
  • Q 1 is the amount of heat obtained from the area of the endothermic peak based on the excess ⁇ gel
  • the emulsified droplets are the amount of heat obtained from the area of an endothermic peak based on the ⁇ gel film structure covering
  • Q 2 the ratio of the amount of heat obtained from the area of the endothermic peak based on the excess of ⁇ gel against heat obtained from the area of the whole endothermic peak Q 1 From the viewpoint of viscosity stability, / Q 0 is preferably 0.7 or less, more preferably 0.2 or less, and even more preferably 0.1 or less.
  • the calories Q 0 , Q 1 , and Q 2 obtained from the area of the endothermic peak are obtained as follows. That is, a DDSC curve which is a differential value of the obtained DSC curve is created, and the temperature at which the slope starts to occur in the DDSC curve is used as the base point.
  • the peak area can be obtained by connecting the base points to the DSC curve (baseline).
  • the area of the entire endothermic peak (cm 2 ) included in the temperature range of 58 ° C to 68 ° C is A 0
  • the area of the endothermic peak based on the excess ⁇ gel (cm 2 ) is A 1
  • the ⁇ gel film covering the emulsified droplets are obtained as follows. That is, a DDSC curve which is a differential value of the obtained DSC curve is created, and the temperature at which the slope starts to occur in the DDSC curve is used as the base point.
  • the peak area can be obtained by connecting the base points to the DSC curve (baseline).
  • the calories Q 0 , Q 1 , and Q 2 are expressed by the following equations.
  • mi is the sample amount (g)
  • c is the feed rate of recorded data (cm / s)
  • P is the value of how many joules the vertical axis 1 cm of the DSC curve corresponds to in 1 second (J / cm ⁇ . s).
  • the film thickness of the ⁇ -gel film in the ⁇ -gel film structure is preferably 5 to 20 nm, more preferably 5 to 10 nm, from the viewpoint of viscosity stability and emulsion stability.
  • the film thickness of the ⁇ -gel film means the average value of the film thickness of the ⁇ -gel film of 100 emulsified droplets measured by electron microscope observation.
  • the oil-in-water emulsified composition of the present invention can be used as cosmetics, quasi-drugs, pharmaceuticals, etc., and its forms are makeups such as cosmetics, beauty essences, undiluted sprays, hair protectants, and liquid foundations. It is a liquid product such as a preparation.
  • liquid means that the viscosity measured by the method described in Examples is 100 mPa ⁇ s or less, preferably 50 to 0 mPa ⁇ s.
  • Test Example 1 Structural change and stability depending on the particle size of the emulsified droplet
  • An oil-in-water composition having an average emulsified particle size of 80 nm, 110 nm, 170 nm and 1 ⁇ m was prepared by the following formulation and production method. DSC measurement was performed on each of the obtained compositions under the following conditions. Further, the compositions having an average emulsified particle size of 80 nm and 110 nm were subjected to X-ray diffraction by the following method. Further, the composition having an average emulsified particle size of 110 nm was observed with an electron microscope by the following method. The results are shown in FIGS.
  • High-pressure dispersion treatment (pressure 130 MPa) with a microfluidizer was performed twice for D-1: C to prepare an oil-in-water emulsified composition having an average emulsified particle size of 80 nm.
  • High-pressure dispersion treatment pressure 80 MPa
  • a microfluidizer was carried out twice for D-3: C to prepare an oil-in-water emulsified composition having an average emulsified particle size of 170 nm.
  • the ⁇ -gel is mainly dispersed as a surplus ⁇ -gel in the continuous phase, but at 110 nm, the ⁇ -gel covering the emulsified droplet and the surplus ⁇ -gel coexist.
  • the ⁇ -gel mainly exists as a coating for emulsified droplets.
  • the formation of an ⁇ -gel film structure covering the emulsified droplets means that a peak exists at 15 nm -1 in X-ray diffraction (Fig. 2) and an electron micrograph. This is also supported by (Fig. 3).
  • the amount of heat Q 0 obtained from the total area of the endothermic peak the amount of heat Q 1 obtained from the area of the endothermic peak based on the surplus ⁇ gel, and the area of the endothermic peak based on the ⁇ gel film structure covering the emulsified droplets.
  • the quantity of heat Q 2 to which sought to calculate the analysis software determined using EXSTAR6000, ratio Q 1 / Q 0 of the amount of heat obtained from the area of the endothermic peak based on the excess of ⁇ gel against heat obtained from the area of the whole endothermic peaks.
  • the results are shown in Table 1.
  • the average emulsified particle size is 110 nm and the ratio Q 1 / Q 0 is 0, as compared with the test example in which the average emulsified particle size is 170 nm and the ratio Q 1 / Q 0 is 0.783.
  • the test example having a viscosity of 136 and the test example having an average emulsified particle size of 80 nm and a ratio of Q 1 / Q 0 of 0 maintained a viscosity of 100 mPa ⁇ s or less without thickening even after storage at 50 ° C. for 1 month. It was confirmed that the viscosity stability over time was excellent.
  • Reference Example 1 Preparation of liposome-containing lotion
  • the lotion having the composition shown below was prepared by the following production method. The obtained lotion was observed with an electron microscope. An electron micrograph is shown in FIG.
  • the emulsified droplet having the ⁇ -gel membrane structure of the present invention in FIG. 3 has an oil phase inside, whereas the liposome in FIG. 4 does not have an oil phase inside, which is clearly different.
  • the liposome forms a multi-lamellar membrane, it can be seen that the membrane structure exists in a plurality of layers, but the ⁇ -gel membrane structure of the present invention does not have a layered membrane structure, and the number of lamellar membranes is not observed. It turns out that there are few.
  • the thickness of the ⁇ -gel film of the present invention is about 3 molecules of the linear saturated higher alcohol having 16 or more carbon atoms (the ⁇ -gel film is a higher alcohol trimolecular film).
  • the thickness of the ⁇ -gel film is preferably 5 to 20 nm, more preferably 5 to 10 nm from the viewpoint of viscosity stability and emulsion stability, and a linear saturated higher alcohol having 16 or more carbon atoms is approximately used. It is more preferable that the amount is 3 molecules (the ⁇ -gel film is a higher alcohol tri-molecule film).
  • Toners having the compositions shown in Tables 3 to 6 below were prepared by the following production methods.
  • the obtained lotion was evaluated for its viscosity and emulsified state immediately after production and after storage at 50 ° C. for 1 month according to the following measuring method and criteria.
  • the existence of the ⁇ -gel membrane structure covering the emulsified droplet was evaluated by the following method.
  • the results are also shown in Tables 3-6.
  • the numerical values in the compositions of Tables 3 to 6 mean%.
  • Nikkor SMT manufactured by Nikko Chemicals
  • Amisoft HA-P manufactured by Koei Kogyo Co., Ltd.
  • 3 Nikkor DDP-8 manufactured by Nikko Chemicals
  • Example 1 No. 1 to 15 were uniformly heated, mixed and dissolved.
  • B No. 16 to 19 were uniformly heated, mixed and dissolved.
  • C A was added to B and emulsified and mixed.
  • D C was cooled, and high-pressure dispersion treatment (pressure 200 MPa) was performed twice with a microfluidizer to obtain a lotion.
  • Example 2 (Examples 2, 11-14) A: No. 1 to 15 were uniformly heated, mixed and dissolved. B: No. 16 to 19 were uniformly heated, mixed and dissolved. C: A was added to B and emulsified and mixed. D: C was cooled, and high-pressure dispersion treatment (pressure 200 MPa) was performed once with a microfluidizer to obtain a lotion.
  • Examples 3 to 6, 9 and Comparative Examples 1 to 12 A: No. 1 to 15 were uniformly heated, mixed and dissolved. B: No. 16 to 19 were uniformly heated, mixed and dissolved. C: A was added to B and emulsified and mixed. D: C was cooled, and high-pressure dispersion treatment (pressure 100 MPa) was performed twice with a microfluidizer to obtain a lotion.
  • the lotions of Examples 1 to 14 all showed the presence of an ⁇ -gel film structure covering the emulsified droplets, became liquid immediately after production, and increased even after storage at 50 ° C. for 1 month. It maintained a viscosity of 100 mPa ⁇ s or less without sticking. In addition, no separation or creaming occurred, and a good emulsified state was maintained. On the other hand, in the lotions of Comparative Examples 1 and 2 having an average emulsified particle size of 170 nm or more, the existence of the ⁇ -gel film structure was not confirmed, and the viscosity increased with time.
  • the lotions of Comparative Examples 3 to 5 in which the component (A) a linear saturated higher alcohol having 16 or more carbon atoms was replaced with a branched one or one having less than 16 carbon atoms were separated immediately after production. Was observed (initial separation).
  • a nonionic surfactant is used instead of the component (B)
  • initial separation occurs (Comparative Example 6)
  • a cationic surfactant or an anionic surfactant other than the component (B) is used.
  • the existence of the ⁇ -gel film structure was not confirmed in the product, and even if the average emulsified particle size was 160 nm or less, the emulsion stability and viscosity stability were improved by separating after storage at 50 ° C.
  • Test Example 2 Stability test of oil-soluble active ingredient A lotion having the composition shown in Table 7 below was prepared by the following production method. The stability of the oil-soluble active ingredient of the obtained lotion was evaluated by the following method.
  • Residual absorbance (%) (absorbance of sample after storage at 50 ° C for 1 month) ⁇ 100 / (absorbance of sample immediately after production)
  • Example 15 As shown in Table 7, in the lotion of Example 15, the fading of astaxanthin after storage at 50 ° C. for 1 month was clearly suppressed as compared with Comparative Example 13. This is because, in Example 15, the ⁇ -gel membrane structure covers the emulsified droplets and the emulsified droplet interface becomes stronger, so that the contact of astaxanthin with water or the like associated with the ostwald drying is suppressed, and as a result, the decomposition of astaxanthin is suppressed. However, in the cosmetic solution of Comparative Example 13, the ⁇ -gel film structure is not formed around the emulsified droplets, so that it is considered that contact of astaxanthin with water and the like and accompanying decomposition occur. Similarly, it was confirmed that ⁇ -carotene and ubidecalenone were stably maintained even after storage at 50 ° C. for 1 month.
  • Test Example 3 Ratio and stability of polar oil to non-polar oil A lotion having the composition shown in Table 8 below was prepared by the following production method. The obtained lotion was evaluated for its viscosity and emulsified state immediately after production and after storage at 50 ° C. for 1 month in the same manner as in Examples 1 to 14. The stability of astaxanthin was evaluated in the same manner as in Test Example 2. The results are also shown in Table 6.
  • the cosmetics of Examples 19 to 21 and 25 had better viscosity stability and emulsion stability after storage at 50 ° C. for 1 month than those of Example 27. .. Furthermore, the lotions of Examples 22 to 24 and 26 have higher viscosity stability, emulsion stability and oil-soluble active ingredient stability after storage at 50 ° C. for 1 month than those of Example 28. It was good. This is because the lower the mass ratio of polar oil to non-polar oil ((polar oil) / (non-polar oil)), the lower the compatibility with linear saturated higher alcohol, and the stability of the ⁇ -gel film structure over time at high temperature. This is thought to be due to the improved polarity.
  • Example 27 Toner (ingredient) (%) 1. 1. Dimethicone (25 ° C 6 mPa ⁇ s) 4.5 2. 2. Ethylhexyl palmitate * 9 0.5 3. 3. Setostearyl alcohol 1.5 4. Behenyl alcohol 0.8 5. Setostearyl alcohol 0.8 6. Sodium N-stearoyl-N-methyltaurine 0.7 7. Glycerin 1.0 8.1,3-butylene glycol 12.0 9. Tripropylene glycol 0.5 10. Citric acid 0.01 11. Na citrate 0.01 12. Remaining amount of purified water * 9 Sarakos P-8 (manufactured by Nisshin Oillio Group) (Production method) A: No. 1 to 5 were uniformly heated, mixed and dissolved.
  • B No. 6 to 12 were uniformly heated, mixed and dissolved.
  • C A was added to B and emulsified and mixed.
  • D C was cooled, and high-pressure dispersion treatment (pressure 130 MPa) was performed twice with a microfluidizer to obtain a lotion.
  • the lotion of Example 27 obtained as described above was a liquid of 30 mPa ⁇ s immediately after production, had an average emulsified particle size of 80 nm, and was in a good emulsified state. Viscosity stability and emulsification stability at 50 ° C. after 1 month were also good.
  • the oil-in-water emulsified composition of the present invention is liquid but has excellent viscosity stability and emulsification stability over time, and therefore can be used for liquid cosmetics, quasi-drugs, and the like.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention addresses the problem of providing an oil-in-water emulsified composition that is liquid, but has excellent temporal viscosity stability and emulsification stability. The liquid oil-in-water composition according to the present invention as a solution to the problem is characterized by containing components (A)-(C): (A) a straight-chain saturated higher alcohol having 16 or more carbon atoms; (B) at least one anionic surfactant selected from the group consisting of sodium N-stearoyl-N-methyl taurate, and N-stearoyl-L-glutamic acid and salts thereof; and (C) a liquid oil, wherein the molar content ratio (A/B) of the component (A) to the component (B) is 2.8-6, the mass content ratio ((A+B)/C) of the total of the components (A) and (B) to the component (C) is 0.3-0.75, and the average emulsified particle size thereof is 160 nm or less.

Description

液状水中油型組成物Liquid oil-in-water composition

 本発明は、液状水中油型組成物に関し、さらに詳細には、液状でありながら経時的な粘度安定性及び乳化安定性に優れる液状水中油型組成物に関する。 The present invention relates to a liquid oil-in-water composition, and more particularly to a liquid oil-in-water composition which is liquid but has excellent viscosity stability and emulsion stability over time.

 従来、水中油型組成物において、油剤の含有量を高くすると、経時的に分離やクリーミングが生じるなど乳化安定性が低下するという問題があった。これに対し、親水性アニオン系界面活性剤と高級脂肪族アルコールを所定のモル比で配合し、ゲル転移温度が60℃以上となるαゲルを形成させる技術や(特許文献1)、高級アルコールとアニオン性界面活性剤を所定のモル比で混合した混合物と、特定のIOB値の水溶性溶媒と水を所定の質量比で混合した混合物とからなる両連続マイクロエマルション相のαゲル中間体組成物を調製し、この組成物に加温した油分を添加し、次いで水を添加、撹拌することによってαゲル形成を誘発させる技術など(特許文献2)、αゲルを利用して乳化安定性の向上を図る試みがなされている。 Conventionally, in the oil-in-water composition, when the content of the oil agent is increased, there is a problem that the emulsification stability is lowered due to separation and creaming over time. On the other hand, a technique of blending a hydrophilic anionic surfactant and a higher fatty alcohol in a predetermined molar ratio to form an α-gel having a gel transition temperature of 60 ° C. or higher (Patent Document 1), and higher alcohols An α-gel intermediate composition of a bicontinuous microemulsion phase consisting of a mixture of an anionic surfactant mixed at a predetermined molar ratio and a mixture of a water-soluble solvent having a specific IOB value and water at a predetermined mass ratio. (Patent Document 2), such as a technique for inducing α-gel formation by adding warm oil to this composition, then adding water and stirring (Patent Document 2), to improve emulsion stability by using α-gel. Attempts have been made to achieve this.

 αゲルは両親媒性物質の形成する自己組織体の一つで、固体の水和結晶(コアゲル)とラメラ液晶の中間に位置し、結晶状態を保ちながらもその親水基間に多量の水を保持した状態にある。コアゲルのようなほとんど水を保持できない結晶は、分子自体が傾いてより密に充填した状態であるのに対し、ラメラ液晶は2分子膜の構造が流動性に富み、液体状態であるため多くの水を保持できる。αゲルもラメラ液晶と同じように界面活性剤が層状に並んでいるが、六方晶に規則正しく充填されているため、回転運動は保持されているものの、ラメラ液晶と比べ疎水基の運動性に乏しく、分子の運動は制御されている。このような構造に基づく運動性の違いを示差走査熱量分析(DSC)などで観測すると、ゲル-液晶相転移として熱の移動が観測できる。 α-gel is one of the self-assembling bodies formed by amphipathic substances. It is located between the solid hydrated crystal (core gel) and the lamellar liquid crystal, and a large amount of water is allowed between the hydrophilic groups while maintaining the crystalline state. It is in a held state. Crystals that can hardly hold water, such as core gel, are in a state where the molecules themselves are tilted and packed more densely, whereas in lamellar liquid crystal, the structure of the bilayer liquid crystal is rich in fluidity and is in a liquid state, so many Can hold water. Similar to lamellar liquid crystal, α-gel has surfactants arranged in layers, but since it is regularly packed in hexagonal crystals, it retains rotational motion, but it has less hydrophobic group mobility than lamellar liquid crystal. , The movement of molecules is controlled. When the difference in motility based on such a structure is observed by differential scanning calorimetry (DSC) or the like, heat transfer can be observed as a gel-liquid crystal phase transition.

 しかし、αゲルはラメラ液晶とコアゲルの中間相であるため通常不安定であり、上記特許文献1及び2の技術によって得られるαゲル含有水中油型乳化組成物も、経時的に粘度が上昇するなど粘度安定性に欠ける場合があった。また上記特許文献1及び2の技術は、αゲルの増粘作用に基づき乳化安定性を付与するものであり、製造直後から比較的高粘度となるため、化粧水などの液状の化粧料に当該技術を適用することは困難であった。 However, since the α-gel is an intermediate phase between the lamellar liquid crystal and the core gel, it is usually unstable, and the viscosity of the α-gel-containing oil-in-water emulsified composition obtained by the techniques of Patent Documents 1 and 2 also increases with time. In some cases, the viscosity stability was lacking. Further, the techniques of Patent Documents 1 and 2 impart emulsification stability based on the thickening action of α-gel, and since the viscosity becomes relatively high immediately after production, it is applicable to liquid cosmetics such as lotion. It was difficult to apply the technology.

特開2001-348325号公報Japanese Unexamined Patent Publication No. 2001-348325 特開2016-14011号公報Japanese Unexamined Patent Publication No. 2016-14011

J.Soc.Cosmet.Chem.Jpn.30(3)310-320(1996)J.Soc.Cosmet.Chem.Jpn.30 (3) 310-320 (1996) Food Biophysics, September 2012,Volume 7,Issue 3,pp 227-235Food Biophysics, September 2012, Volume 7, Issue 3, pp 227-235 J.Soc.Cosmet.Chem.Jpn.44(2)103-117(2010)J.Soc.Cosmet.Chem.Jpn.44 (2) 103-117 (2010)

 本発明の課題は、液状でありながら、経時的な粘度安定性及び乳化安定性に優れる水中油型乳化組成物を提供することにある。 An object of the present invention is to provide an oil-in-water emulsification composition which is liquid but has excellent viscosity stability and emulsion stability over time.

 本発明者らは上記課題を解決するために鋭意研究を行った結果、直鎖飽和高級アルコールに対し、N-ステアロイル-N-メチルタウリンナトリウム又はN-ステアロイル-L-グルタミン酸及びその塩など特定のアニオン性界面活性剤を所定量で組み合わせたうえで、形成される乳化滴の粒径を160nm以下に調整することによって、経時的に増粘することなく製造後から長期間にわたって液状の性状を保持できるとともに、クリーミングや分離等を生じることなく良好な乳化状態が安定的に維持されることを見出し、本発明を完成するに至った。 As a result of diligent research to solve the above problems, the present inventors have specified specific N-stearoyl-N-methyltaurine sodium or N-stearoyl-L-glutamic acid and salts thereof with respect to the linear saturated higher alcohol. By adjusting the particle size of the emulsified droplets formed to 160 nm or less after combining an anionic surfactant in a predetermined amount, the liquid properties are maintained for a long period of time after production without thickening over time. At the same time, they have found that a good emulsified state can be stably maintained without causing creaming or separation, and have completed the present invention.

 すなわち本発明は、次の成分(A)~(C);
 (A)炭素数16以上の直鎖飽和高級アルコール
 (B)N-ステアロイル-N-メチルタウリンナトリウム並びにN-ステ
    アロイル-L-グルタミン酸及びその塩よりなる群から選択される
    1種以上のアニオン性界面活性剤
 (C)液状油
 を含有し、成分(B)に対する成分(A)の含有モル比(A/B)が2.8~6、成分(C)に対する成分(A)及び(B)の合計の含有質量比((A+B)/C)が0.3~0.75であって、平均乳化粒径が160nm以下の液状水中油型組成物である。
That is, the present invention describes the following components (A) to (C);
(A) Linear saturated higher alcohol having 16 or more carbon atoms (B) One or more anionic ones selected from the group consisting of N-stearoyl-N-methyltaurine sodium and N-stearoyl-L-glutamic acid and salts thereof. Surfactant (C) Contains liquid oil, the molar ratio (A / B) of the component (A) to the component (B) is 2.8 to 6, and the components (A) and (B) to the component (C). A liquid oil-in-water composition having a total mass ratio ((A + B) / C) of 0.3 to 0.75 and an average emulsified particle size of 160 nm or less.

 本発明の水中油型乳化組成物は、液状でありながら経時的な粘度安定性及び乳化安定性に優れるものであり、長期間にわたって増粘することなく液状の性状を保持し、かつクリーミングや分離等を生じることなく良好な乳化状態を安定して維持することができる。また組成物中に油溶性有効成分を含有させた場合には、その経時的安定性を向上させることができ、当該有効成分に基づく作用効果を安定的に維持することが可能である。 The oil-in-water emulsified composition of the present invention is liquid but excellent in viscosity stability and emulsion stability over time, retains liquid properties without thickening for a long period of time, and is creamed and separated. It is possible to stably maintain a good emulsified state without causing such problems. Further, when the oil-soluble active ingredient is contained in the composition, the stability over time can be improved, and the action and effect based on the active ingredient can be stably maintained.

試験例1における平均乳化粒径80nm、110nm,170nm,1μmの組成物について示差走査熱量分析(DSC)の結果を示す図である。It is a figure which shows the result of the differential scanning calorimetry (DSC) about the composition of the average emulsified particle size 80 nm, 110 nm, 170 nm, 1 μm in Test Example 1. 試験例1における平均乳化粒径80nm、110nmの組成物についてX線回折の結果を示す図である。It is a figure which shows the result of X-ray diffraction about the composition of the average emulsification particle diameter 80nm, 110nm in Test Example 1. 試験例1における平均乳化粒径110nmの組成物についての電子顕微鏡写真である。3 is an electron micrograph of the composition having an average emulsified particle size of 110 nm in Test Example 1. 参考例1におけるリポソームの電子顕微鏡写真である。It is an electron micrograph of the liposome in Reference Example 1.

 成分(A)炭素数16以上の直鎖飽和高級アルコールとしては、例えば、セチルアルコール、セトステアリルアルコール、ステアリルアルコール、アラキジルアルコール、ベヘニルアルコール、リグノセリルアルコール、セリルアルコール等が挙げられ、これらの1種または2種以上を使用することができる。これらの中でも、粘度安定性及び乳化安定性の観点から、セトステアリルアルコール、ステアリルアルコール、アラキジルアルコール、ベヘニルアルコール等が好ましく、特にセトステアリルアルコール、ステアリルアルコールが好ましい。本発明の水中油型組成物中(以下、単に「組成物」ということがある)の成分(A)の含有量は、粘度安定性及び乳化安定性の観点から0.5~2質量%(以下、単に「%」という)が好ましく、1~1.7%がより好ましい。 Component (A) Examples of the linear saturated higher alcohol having 16 or more carbon atoms include cetyl alcohol, cetostearyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol, lignoceryl alcohol, and ceryl alcohol, and one of them. Alternatively, two or more types can be used. Among these, from the viewpoint of viscosity stability and emulsion stability, setostearyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol and the like are preferable, and setostearyl alcohol and stearyl alcohol are particularly preferable. The content of the component (A) in the oil-in-water composition of the present invention (hereinafter, may be simply referred to as “composition”) is 0.5 to 2% by mass (from the viewpoint of viscosity stability and emulsion stability). Hereinafter, it is preferably simply referred to as “%”), and more preferably 1 to 1.7%.

 成分(B)は、アニオン性界面活性剤であるN-ステアロイル-N-メチルタウリンナトリウム、N-ステアロイル-L-グルタミン酸及びその塩であり、N-ステアロイル-L-グルタミン酸塩としては、ナトリウム塩、カリウム塩、マグネシウム塩などが挙げられ、これらの1種または2種以上を使用することができる。これらの中でも、粘度安定性及び乳化安定性の観点からN-ステアロイル-N-メチルタウリンナトリウム、N-ステアロイル-L-グルタミン酸、N-ステアロイル-L-グルタミン酸ジナトリウムが好ましい。本発明の組成物中の成分(B)の含有量は、粘度安定性及び乳化安定性の観点から0.4~1%が好ましく、0.5~0.9%がより好ましい。 The component (B) is N-stearoyl-N-methyltaurine sodium, N-stearoyl-L-glutamic acid and a salt thereof, which are anionic surfactants, and the N-stearoyl-L-glutamic acid salt is a sodium salt. Examples thereof include potassium salts and magnesium salts, and one or more of these can be used. Among these, N-stearoyl-N-methyltaurine sodium, N-stearoyl-L-glutamic acid, and N-stearoyl-L-glutamic acid disodium are preferable from the viewpoint of viscosity stability and emulsion stability. The content of the component (B) in the composition of the present invention is preferably 0.4 to 1%, more preferably 0.5 to 0.9% from the viewpoint of viscosity stability and emulsion stability.

 成分(C)液状油は、常温(25℃)で液状を呈するものであれば特に制限なく使用でき、例えば、イソドデカン、イソヘキサデカン、軽質イソパラフィン、流動パラフィン(ミネラルオイル)、スクワラン、スクワレン、α-オレフィンオリゴマー、ポリブテン、流動イソパラフィン、重質流動イソパラフィン、ポリイソブチレン、水添ポリイソブテン等の炭化水素類;アブラナ種子油、アボカド油、アルモンド油、アンズ核油、エゴマ油、オレンジ油、オリーブ油、キウイ種子油、ゴマ油、小麦胚芽油、米胚芽油、コメヌカ油、サフラワー油、セージ油、大豆油、チャ種子油、トウモロコシ油、ナタネ油、月見草油、ツバキ油、パーシック油、ハトムギ油、ピーナッツ油、ひまわり油、ブドウ種子油、メドウフォーム油、ローズマリー油、ホホバ油、マカデミアナッツ油、ラベンダー油、ローズヒップ油、ミンク油等の動植物油;トリ2-エチルヘキサン酸グリセリル、イソノナン酸イソトリデシル、イソノナン酸イソノニル、2-エチルヘキサン酸セチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸-2-エチルヘキシル、ミリスチン酸オクチルドデシル、トリオクタン酸グリセリル、トリ(カプリル・カプリン酸)グリセリル、ジイソステアリン酸グリセリル、トリイソステアリン酸グリセリル、デカイソステアリン酸デカグリセリル(デカイソステアリン酸ポリグリセリル-10)、ジカプリン酸プロピレングリコール、ジカプリン酸ネオペンチルグリコール、トリイソステアリン酸ポリグリセリル、リンゴ酸ジイソステアリル、ジエチルヘキサン酸ネオペンチルグリコール、テトライソステアリン酸ペンタエリトリット、テトラ2-エチルヘキサン酸ペンタエリトリット、ペンタイソステアリン酸ジペンタエリトリット、炭酸ジアルキル、シクロヘキサン-1,4-ジカルボン酸ビスエトキシジグリコール、ダイマージリノレイル水添ロジン縮合物等のエステル類;オレイン酸、イソステアリン酸等の脂肪酸類;オレイルアルコール、2-オクチルドデカノール、2-デシルテトラデカノール、イソステアリルアルコール、2-ヘキシルデカノール等の高級アルコール類;ジメチルポリシロキサン(ジメチコン)、メチルトリメチコン、メチルフェニルポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、テトラメチルテトラハイドロジェンシクロテトラシロキサン、テトラメチルテトラフェニルシクロテトラシロキサン、テトラメチルテトラトリフロロプロピルシクロテトラシロキサン、ペンタメチルペンタトリフロロプロピルシクロペンタシロキサン、ポリエーテル変性メチルポリシロキサン、オレイル変性メチルポリシロキサン、ポリビニルピロリドン変性メチルポリシロキサン等のシリコーン油類;パーフルオロポリエーテル、パーフルオロデカン、パーフルオロオクタン等のフッ素系油剤類;酢酸ラノリン、ラノリン脂肪酸イソプロピル、ラノリンアルコール等のラノリン誘導体類;パラメトキシケイ皮酸2-エチルヘキシル、サリチル酸エチルヘキシル等の液状の紫外線吸収剤等が挙げられ、これらの1種または2種以上を用いることができる。 The liquid oil of component (C) can be used without particular limitation as long as it is liquid at room temperature (25 ° C.). For example, isododecane, isohexadecane, light isoparaffin, liquid paraffin (mineral oil), squalane, squalane, α-. Hydrocarbons such as olefin oligomer, polybutene, liquid isoparaffin, heavy liquid isoparaffin, polyisobutylene, hydrogenated polyisobutene; abrana seed oil, avocado oil, almond oil, apricot kernel oil, egoma oil, orange oil, olive oil, kiwi seed oil , Sesame oil, wheat germ oil, rice germ oil, rice bran oil, safflower oil, sage oil, soybean oil, tea seed oil, corn oil, rapeseed oil, evening primrose oil, camellia oil, persic oil, honeybee oil, peanut oil, sunflower Animal and vegetable oils such as oils, grape seed oils, meadowfoam oils, rosemary oils, jojoba oils, macadamia nut oils, lavender oils, rosehip oils, mink oils; Cetyl 2-ethylhexanoate, isopropyl myristate, isopropyl palmitate, -2-ethylhexyl palmitate, octyldodecyl myristate, glyceryl trioctanoate, glyceryl tri (capril capric acid), glyceryl diisostearate, glyceryl triisostearate, deca Decaglyceryl isostearate (polyglyceryl decisostearate-10), propylene glycol dicaprate, neopentyl glycol dicaprate, polyglyceryl triisostearate, diisostearyl malate, neopentyl glycol diethylhexanate, pentaerythrit tetraisostearate, tetra Esters such as pentaerythrit 2-ethylhexanoic acid, dipentaerythrit pentaisostearate, dialkyl carbonate, bisethoxydiglycol cyclohexane-1,4-dicarboxylate, hydrogenated rosin condensate of dimer dilinoleyl; oleic acid, Fatty acids such as isostearic acid; higher alcohols such as oleyl alcohol, 2-octyldodecanol, 2-decyltetradecanol, isostearyl alcohol, 2-hexyldecanol; dimethylpolysiloxane (dimethicone), methyltrimethicone, methylphenylpoly Siloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, tetramethyltetrahydrodi Encyclotetrasiloxane, Tetramethyltetraphenylcyclotetrasiloxane, Tetramethyltetratrifluoropropylcyclotetrasiloxane, Pentamethylpentatrifluoropropylcyclopentasiloxane, polyether-modified methylpolysiloxane, oleyl-modified methylpolysiloxane, polyvinylpyrrolidone-modified Silicone oils such as methylpolysiloxane; Fluorine oils such as perfluoropolyether, perfluorodecane, and perfluorooctane; lanolin derivatives such as lanolin acetate, lanolin fatty acid isopropyl, and lanolin alcohol; paramethoxysilicate skin acid 2- Examples thereof include liquid ultraviolet absorbers such as ethylhexyl and ethylhexyl salicylate, and one or more of these can be used.

 これらの中でも、粘度安定性及び乳化安定性の観点から非極性油が好ましく、例えば、イソドデカン、イソヘキサデカン、軽質イソパラフィン、流動パラフィン(ミネラルオイル)、スクワラン、スクワレン、α-オレフィンオリゴマー、ポリブテン、流動イソパラフィン、重質流動イソパラフィン、ポリイソブチレン、水添ポリイソブテン等の炭化水素類、ジメチルポリシロキサン(ジメチコン)、メチルトリメチコン、メチルフェニルポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、テトラメチルテトラハイドロジェンシクロテトラシロキサン、テトラメチルテトラフェニルシクロテトラシロキサン、テトラメチルテトラトリフロロプロピルシクロテトラシロキサン、ペンタメチルペンタトリフロロプロピルシクロペンタシロキサン、ポリエーテル変性メチルポリシロキサン、オレイル変性メチルポリシロキサン、ポリビニルピロリドン変性メチルポリシロキサン等のシリコーン油類等が挙げられ、これらの1種又は2種以上を用いることができる。特に流動パラフィン(ミネラルオイル)、ジメチルポリシロキサン(ジメチコン)が好適に用いられる。本発明の組成物中の成分(C)の含有量は、粘度安定性及び乳化安定性の観点から、1~10%が好ましく、1.5~6.5%がより好ましい。また非極性油に対する極性油の含有質量割合((極性油)/(非極性油))は、油溶性有効成分や粘度・乳化の安定性向上の観点から、0.5以下であることが好ましく、0.3以下であることがより好ましい。なお、成分(C)液状油には、後述する成分(D)油溶性有効成分は含まれない。 Among these, non-polar oil is preferable from the viewpoint of viscosity stability and emulsion stability, and for example, isododecane, isohexadecane, light isoparaffin, liquid paraffin (mineral oil), squalane, squalane, α-olefin oligomer, polybutene, and liquid isoparaffin. , Heavy fluid isoparaffin, polyisobutylene, hydrogenated polyisobutene and other hydrocarbons, dimethylpolysiloxane (dimethicone), methyltrimethicone, methylphenylpolysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, tetramethyltetrahydro Gencyclotetrasiloxane, tetramethyltetraphenylcyclotetrasiloxane, tetramethyltetratrifluoropropylcyclotetrasiloxane, pentamethylpentatrifluoropropylcyclopentasiloxane, polyether-modified methylpolysiloxane, oleyl-modified methylpolysiloxane, polyvinylpyrrolidone-modified methyl Examples thereof include silicone oils such as polysiloxane, and one or more of these can be used. In particular, liquid paraffin (mineral oil) and dimethylpolysiloxane (dimethicone) are preferably used. The content of the component (C) in the composition of the present invention is preferably 1 to 10%, more preferably 1.5 to 6.5% from the viewpoint of viscosity stability and emulsion stability. The mass ratio of polar oil to non-polar oil ((polar oil) / (non-polar oil)) is preferably 0.5 or less from the viewpoint of improving the oil-soluble active ingredient and the stability of viscosity and emulsification. , 0.3 or less is more preferable. The liquid oil of the component (C) does not include the oil-soluble active ingredient of the component (D) described later.

 本発明に用いる極性油は、粘度安定性及び乳化安定性の観点から、IOB(Inorganic-Organicbalance)が、0.05~0.8であることがより好ましく、0.05~0.6であることがさらにより好ましい。本発明に用いる非極性油のIOBは、粘度安定性及び乳化安定性の観点から、0.05未満であることが好ましく、0.03以下であることがより好ましい。 The polar oil used in the present invention preferably has an IOB (Inorganic-Organic balance) of 0.05 to 0.8, more preferably 0.05 to 0.6, from the viewpoint of viscosity stability and emulsion stability. Is even more preferable. The IOB of the non-polar oil used in the present invention is preferably less than 0.05, more preferably 0.03 or less, from the viewpoint of viscosity stability and emulsion stability.

 ここで、本発明におけるIOBとは、下記(式1)で計算されるものである。
  IOB=(Σ無機性値/Σ有機性)・・・(式1)
 すなわち、IOBは、各種原子及び官能基毎に設定された「無機性値」、「有機性値」に基づいて、界面活性剤等の有機化合物を構成する原子及び官能基の「無機性値」、「有機性値」を積算することにより算出することができる(甲田善生著、「有機概念図-基礎と応用-」、11~17頁、三共出版、1984年発行参照)。
Here, the IOB in the present invention is calculated by the following (Equation 1).
IOB = (Σ inorganic value / Σ organic) ... (Equation 1)
That is, the IOB is based on the "inorganic value" and "organic value" set for each of various atoms and functional groups, and the "inorganic value" of the atoms and functional groups constituting the organic compound such as a surfactant. , "Organic value" can be calculated by integrating (see Yoshio Koda, "Organic Conceptual Diagram-Basics and Applications-", pp. 11-17, Sankyo Publishing, 1984).

 また、粘度安定性及び乳化安定性の観点から、液状油の混合IOBは、0.8以下であることが好ましく、0.6以下であることがより好ましく、0.4以下であることがさらにより好ましく、0.2以下であることが特に好ましい。 From the viewpoint of viscosity stability and emulsion stability, the mixed IOB of the liquid oil is preferably 0.8 or less, more preferably 0.6 or less, and further preferably 0.4 or less. It is more preferably 0.2 or less, and particularly preferably 0.2 or less.

 ここで、N種の液状油の混合IOB(IOBtotal)は、下記(式2)で計算されるものである。
  IBOtotal=IOB・W+IOB・W+・・・IOB・W
                           ・・・(式2)
   IOB、IOB、IOB:各液状油のIOB
   W、W、W:各液状油の重量分率(W+W+・・・+W=1)
Here, the mixed IOB (IOB total ) of N kinds of liquid oils is calculated by the following (Equation 2).
IBO total = IOB 1・ W 1 + IOB 2・ W 2 + ・ ・ ・ IOB N・ W N
... (Equation 2)
IOB 1 , IOB 2 , IOB N : IOB of each liquid oil
W 1 , W 2 , W N : Weight fraction of each liquid oil (W 1 + W 2 + ... + W N = 1)

 本発明の水中油型乳化組成物においては、粘度安定性及び乳化安定性の観点から、成分(B)に対する成分(A)の含有モル比(A/B)が2.8~6であることが好ましく、2.8~4であることがより好ましい。 In the oil-in-water emulsification composition of the present invention, the molar ratio (A / B) of the component (A) to the component (B) is 2.8 to 6 from the viewpoint of viscosity stability and emulsion stability. Is preferable, and 2.8 to 4 is more preferable.

 また成分(C)に対する成分(A)及び(B)の合計の含有質量比((A+B)/C))が、粘度安定性及び乳化安定性の観点から、0.3~0.75であることが好ましく、0.3~0.72であることがより好ましい。 The total mass ratio of the components (A) and (B) to the component (C) ((A + B) / C)) is 0.3 to 0.75 from the viewpoint of viscosity stability and emulsion stability. It is preferably 0.3 to 0.72, and more preferably 0.3 to 0.72.

 本発明の組成物における水の含有量は、粘度安定性及び乳化安定性の観点から、70~85%が好ましく、75~80%がより好ましい。 The water content in the composition of the present invention is preferably 70 to 85%, more preferably 75 to 80%, from the viewpoint of viscosity stability and emulsion stability.

 本発明の組成物には、水の他に水性溶媒を使用することができる。水性溶媒としては、例えば、エチルアルコール、プロピルアルコール等の低級アルコール類、プロピレングリコール、1,3-ブチレングリコール、ジプロピレングリコール、1,2-ペンタンジオール、ポリエチレングリコール等のグリコール類、グリセリン、ジグリセリン、ポリグリセリン等のグリセロール類等が挙げられ、これらの1種または2種以上を使用することができる。これらの中でも粘度安定性及び乳化安定性の観点から1,3-ブチレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、ポリグリセリンが好ましい。水性溶媒を使用する場合、粘度安定性及び乳化安定性の観点から、水に対する水性溶媒の含有質量割合(水/水性溶媒)を5~20とすることが好ましく、6~15がより好ましい。 An aqueous solvent can be used in addition to water for the composition of the present invention. Examples of the aqueous solvent include lower alcohols such as ethyl alcohol and propyl alcohol, glycols such as propylene glycol, 1,3-butylene glycol, dipropylene glycol, 1,2-pentanediol and polyethylene glycol, glycerin and diglycerin. , Glycerols such as polyglycerin, and the like, and one or more of these can be used. Among these, 1,3-butylene glycol, dipropylene glycol, glycerin, diglycerin, and polyglycerin are preferable from the viewpoint of viscosity stability and emulsion stability. When an aqueous solvent is used, the mass ratio of the aqueous solvent to water (water / aqueous solvent) is preferably 5 to 20, more preferably 6 to 15, from the viewpoint of viscosity stability and emulsion stability.

 本発明の組成物には、さらに成分(D)油溶性有効成分を含有させることができる。油溶性有効成分としては、トコフェロール、カロチノイド、レチノール、セラミド及びグリチルレチン酸並びにこれらのエステル;油溶性甘草、油溶性ヨクイニンエキス、油溶性ローズマリーエキス、ユビデカレノンなどが挙げられ、これらの1種または2種以上を使用することができる。成分(D)としては、カロチノイドおよびこのエステルからなる群から選ばれる1種または2種以上が好ましい。カロチノイドとしては、アクチニオエリスロール、アスタキサンチン、ビキシン、カンタキサンチン、カプサンチン、カプソルビン、β-8’-アポ-カロテナール(アポカロテナール)、β-12’-アポ-カロテナール、α-カロチン、β-カロチン、”カロチン”(α-およびβ-カロチン類の混合物)、γ-カロチン、δ-カロチン、β-クリプトキサンチン、エキネノン、パーム油カロテン、ルティン、リコピン、ビオレリトリン、ゼアキサンチン、フコキサンチン、アンテラキサンチン、ビオラキサンチンなどが挙げられ、カロチノイドのエステルとしては、カロチノイドのうちヒドロキシル基またはカルボキシル基を含有するものと脂肪酸または脂肪アルコールとが1つまたは複数のエステル結合を形成したエステルなどを挙げることができる。特に成分(D)として、アスタキサンチンおよびこのエステルからなる群から選ばれる1種または2種以上が好ましい。エステルを形成する脂肪酸または脂肪アルコールは炭素数8~24の飽和または不飽和の、直鎖または分岐鎖を有する炭化水素鎖を有するものが好ましい。本発明の組成物における成分(D)の含有量は油溶性有効成分の種類によって適宜設定されるが、例えば、0.00001~1%が好ましく、0.00001~0.5がより好ましい。 The composition of the present invention can further contain the component (D) oil-soluble active ingredient. Oil-soluble active ingredients include tocopherol, carotenoid, retinol, ceramide and glycyrrhetinic acid and esters thereof; oil-soluble licorice, oil-soluble yokuinin extract, oil-soluble rosemary extract, ubidecalenone and the like, and one or two of them. The above can be used. As the component (D), one or more selected from the group consisting of carotenoids and esters thereof is preferable. Carotenoids include actinioerythrol, astaxanthin, bixin, cantaxanthin, capsantin, capsorbin, β-8'-apo-carotene (apocarotenal), β-12'-apo-carotene, α-carotene, β-carotene, " Carotene "(mixture of α- and β-carotene), γ-carotene, δ-carotene, β-cryptoxanthin, ekinenone, palm oil carotene, rutin, lycopene, biorelitrin, zeaxanthin, fucoxanthin, anteraxanthin, violaxanthin, etc. Examples of the carotenoid ester include an ester in which a carotenoid containing a hydroxyl group or a carboxyl group and a fatty acid or a fatty alcohol form one or more ester bonds. In particular, as the component (D), one or more selected from the group consisting of astaxanthin and this ester is preferable. The fatty acid or fatty alcohol forming the ester is preferably one having a saturated or unsaturated hydrocarbon chain having a straight chain or a branched chain having 8 to 24 carbon atoms. The content of the component (D) in the composition of the present invention is appropriately set depending on the type of the oil-soluble active ingredient, and is preferably 0.00001 to 1%, more preferably 0.00001 to 0.5, for example.

 本発明の組成物には、上記成分の他に、必要に応じ本発明の効果を損なわない範囲において任意成分を使用することができる。任意成分としては、例えば、固形油、粉体、紫外線散乱剤、防腐剤、香料等が挙げられる。 In addition to the above components, any component can be used in the composition of the present invention as long as it does not impair the effects of the present invention. Examples of the optional component include solid oil, powder, ultraviolet scattering agent, preservative, fragrance and the like.

 本発明の組成物は、上記必須成分及び必要に応じ配合される任意成分を公知の方法に従って乳化混合することによって調製することができる。例えば、成分(A)~成分(C)を含む油相と、水を含む水相とをそれぞれ加熱溶解し、水相に油相を添加してディスパーション等を用いて乳化混合した後、マイクロフルイダイザー、アルティマイザー、ナノヴェイタなどを用いて高圧乳化処理することにより本発明の水中油型組成物が調製される。 The composition of the present invention can be prepared by emulsifying and mixing the above-mentioned essential components and optional components to be blended as necessary according to a known method. For example, the oil phase containing the components (A) to (C) and the aqueous phase containing water are respectively heated and dissolved, the oil phase is added to the aqueous phase, emulsified and mixed using a dispersion or the like, and then micron. The oil-in-water composition of the present invention is prepared by high-pressure emulsification treatment using a fluidizer, an ultimateizer, a nanovaita or the like.

 本発明の水中油型組成物の平均乳化粒径は、粘度安定性及び乳化安定性の観点から、160nm以下であり、好ましくは60~130nm、より好ましくは70~120nmである。平均乳化粒径は、高圧乳化処理における圧力、処理時間、処理回数などによって調整することができる。本明細書において平均乳化粒径とは、実施例に記載の方法によって測定された値である。 The average emulsified particle size of the oil-in-water composition of the present invention is 160 nm or less, preferably 60 to 130 nm, and more preferably 70 to 120 nm from the viewpoint of viscosity stability and emulsification stability. The average emulsified particle size can be adjusted by adjusting the pressure in the high-pressure emulsification treatment, the treatment time, the number of treatments, and the like. In the present specification, the average emulsified particle size is a value measured by the method described in Examples.

 本発明の水中油型組成物は、このように平均乳化粒径を160nm以下とすることにより、液状でありながら経時的な粘度安定性に優れたものとなるが、その理由は次のように考えられる。すなわち、本発明の水中油型組成物の製造過程において、成分(A)及び(B)からαゲルが形成されるところ、乳化滴の粒径が大きいと、αゲルの一部は乳化滴の周囲に存在し乳化滴を被覆しているが、それ以外のαゲルは連続相中に分散して存在している状態にある。このような余剰のαゲルが経時的にゲルのネットワークを形成して粘度上昇を引き起こすと考えられる。これに対し乳化滴の粒径を小さくしていくと、乳化滴の周囲に存在するαゲルの割合が高くなり、平均乳化粒径が160nm以下の範囲では、ほとんどのαゲルが乳化滴を被覆して、余剰のαゲルが存在しなくなるため、経時的な粘度上昇が生じなくなる。なお、成分(B)以外のアニオン性界面活性剤やカチオン性界面活性剤を使用した場合には、平均乳化粒径を160nm以下にしたとしても、乳化滴を被覆するαゲル膜構造が形成されないため、経時的な粘度上昇が生じてしまう。 By setting the average emulsified particle size to 160 nm or less in this way, the oil-in-water composition of the present invention becomes excellent in viscosity stability over time while being liquid, and the reason is as follows. Conceivable. That is, in the process of producing the oil-in-water composition of the present invention, when α-gel is formed from the components (A) and (B), if the particle size of the emulsified droplet is large, a part of the α-gel is of the emulsified droplet. It exists in the surroundings and covers the emulsified droplets, but the other α-gels are dispersed in the continuous phase. It is considered that such excess α-gel forms a gel network over time and causes an increase in viscosity. On the other hand, as the particle size of the emulsified droplets is reduced, the proportion of α-gel existing around the emulsified droplets increases, and most α-gels cover the emulsified droplets in the range where the average emulsified particle size is 160 nm or less. As a result, the excess α-gel does not exist, so that the viscosity does not increase over time. When an anionic surfactant or a cationic surfactant other than the component (B) is used, the α-gel film structure that covers the emulsified droplets is not formed even if the average emulsified particle size is 160 nm or less. Therefore, the viscosity increases with time.

 上述のとおり本発明の水中油型組成物においては、乳化滴の全部または一部がαゲルで被覆されていることが好ましい。このような乳化滴を被覆するαゲル膜構造(以下、「αゲル膜構造」ということがある)の存在の有無は、示差走査熱量分析(DSC)測定により確認することができる。すなわち、乳化滴が大きい場合(例えば平均乳化粒径1μm程度)、DSC測定において58℃~68℃の範囲には余剰のαゲルに基づく1つの吸熱ピークが観察されるが、乳化滴の粒径が小さくなるにしたがって、この吸熱ピークが徐々に縮小するとともに、より低温側に乳化滴を被覆するαゲル膜構造に基づく別の吸熱ピークが観察される。このようにDSC測定において、58~68℃の範囲に余剰αゲルとαゲル膜構造それぞれに基づく2つの吸熱ピークが観察されるか、より低温側のαゲル膜構造に基づく1つの吸熱ピークのみが観察される場合には、乳化滴を被覆するαゲル膜構造の存在が認められる。また乳化滴を被覆するαゲル膜構造の存在は、X線回折において15nm-1付近にピークが観察されることによっても確認することができる。すなわち、αゲルの面間隔は約4.15Åであるところ、面間隔と波数qの間にはq=2×π(円周率)/d(面間隔)の式が成り立つことから、その波数は15nm-1となる(非特許文献1及び2、図2参照)。さらに、乳化滴を被覆するαゲル膜構造の存在は電子顕微鏡観察によっても確認することができる(図3参照)。 As described above, in the oil-in-water composition of the present invention, it is preferable that all or part of the emulsified droplets are coated with α-gel. The presence or absence of an α-gel film structure (hereinafter, sometimes referred to as “α-gel film structure”) that covers such emulsified droplets can be confirmed by differential scanning calorimetry (DSC) measurement. That is, when the emulsified droplets are large (for example, the average emulsified particle size is about 1 μm), one heat absorption peak based on the excess α-gel is observed in the range of 58 ° C. to 68 ° C. in the DSC measurement, but the particle size of the emulsified droplets. As the value becomes smaller, this heat absorption peak gradually shrinks, and another heat absorption peak based on the α-gel film structure that coats the emulsified droplet on the lower temperature side is observed. Thus, in the DSC measurement, two endothermic peaks based on the excess α-gel and α-gel membrane structure are observed in the range of 58 to 68 ° C., or only one endothermic peak based on the α-gel membrane structure on the lower temperature side is observed. If is observed, the presence of an α-gel membrane structure covering the emulsified droplets is recognized. The presence of the α-gel film structure covering the emulsified droplet can also be confirmed by observing a peak near 15 nm -1 in X-ray diffraction. That is, where the surface spacing of α-gel is about 4.15 Å, the wave number is because the equation q = 2 × π (pi) / d (plane spacing) holds between the surface spacing and the wave number q. It becomes 15 nm -1 (see Non-Patent Documents 1 and 2 and FIG. 2). Furthermore, the presence of the α-gel film structure covering the emulsified droplets can be confirmed by electron microscope observation (see FIG. 3).

 このような乳化滴を被覆するαゲル膜構造の存在は、油溶性有効成分の安定性向上に寄与すると考えられる。すなわち、水中油型乳化組成物に油溶性有効成分を含有させた場合、油溶性有効成分は主として乳化滴中に存在するが、常に同じ場所に留まることなく、連続相である水相への分子拡散が生じており(オストワルドライプニング(Ostwald ripening)、非特許文献3参照)、油溶性有効成分が連続相の水等と接触することによって油溶性有効成分の劣化が引き起こされる。これに対し本発明では、乳化滴を被覆するαゲル膜構造の存在によって乳化滴界面がより強固となるため、油溶性有効成分のオストワルドライプニングに伴う水等への接触が抑制され、その結果油溶性有効成分の経時安定性が向上するものと推測される。 The presence of such an α-gel film structure that covers the emulsified droplets is considered to contribute to the improvement of the stability of the oil-soluble active ingredient. That is, when the oil-in-water emulsified composition contains an oil-soluble active ingredient, the oil-soluble active ingredient is mainly present in the emulsified droplet, but does not always stay in the same place and is a molecule to the aqueous phase which is a continuous phase. Diffusion has occurred (Ostwald ripening, see Non-Patent Document 3), and the oil-soluble active ingredient comes into contact with continuous-phase water or the like, causing deterioration of the oil-soluble active ingredient. On the other hand, in the present invention, the presence of the α-gel film structure that covers the emulsified droplets makes the emulsified droplet interface stronger, so that the contact of the oil-soluble active ingredient with water or the like due to the Ostwald drying is suppressed, and as a result, the contact with water or the like is suppressed. It is presumed that the stability of the oil-soluble active ingredient over time is improved.

 上記したとおり、DSC測定において58℃~68℃の範囲には、より高温側(60℃以上68℃以下)の余剰のαゲルに基づく吸熱ピーク及びより低温側(58℃以上~60℃未満)の乳化滴を被覆するαゲル膜構造に基づく吸熱ピークのいずれか一方又は双方のピークが含まれ得る。58℃~68℃の温度範囲に含まれる吸熱ピーク全体の面積から求められる熱量(J/g)をQ、余剰のαゲルに基づく吸熱ピークの面積から求められる熱量をQ、乳化滴を被覆するαゲル膜構造に基づく吸熱ピークの面積から求められる熱量をQとすると、吸熱ピーク全体の面積から求められる熱量に対する余剰のαゲルに基づく吸熱ピークの面積から求められる熱量の割合Q/Qは、粘度安定性の観点から、0.7以下であることが好ましく、0.2以下であることがより好ましく、0.1以下であることがさらに好ましい。吸熱ピークの面積から求められる熱量Q,Q,Qは、それぞれ次のようにして求められる。すなわち、得られたDSC曲線の微分値であるDDSC曲線を作成し、DDSC曲線に傾きが生じ始めた温度をベース点とする。DSC曲線に対して、ベース点とベース点を結ぶことで(ベースライン)、ピーク面積を求めることができる。58℃~68℃の温度範囲に含まれる吸熱ピーク全体の面積(cm)をA、余剰のαゲルに基づく吸熱ピークの面積(cm)をA、乳化滴を被覆するαゲル膜構造に基づく吸熱ピークの面積(cm)をAとすると、熱量Q,Q,Qは以下の式で表される。

Figure JPOXMLDOC01-appb-I000001
ここで、miは試料量(g)、cは記録データの送り速度(cm/s)、PはDSC曲線の縦軸1cmが1秒間で何ジュールに相当するかという値(J/cm・s)である。 As described above, in the DSC measurement, the endothermic peak based on the excess α-gel on the higher temperature side (60 ° C or higher and 68 ° C or lower) and the lower temperature side (58 ° C or higher and lower than 60 ° C) are in the range of 58 ° C to 68 ° C. It may include one or both peaks of endothermic peaks based on the α-gel membrane structure that coats the emulsified droplets of. Q 0 is the amount of heat (J / g) obtained from the total area of the endothermic peak included in the temperature range of 58 ° C to 68 ° C, Q 1 is the amount of heat obtained from the area of the endothermic peak based on the excess α gel, and the emulsified droplets. the amount of heat obtained from the area of an endothermic peak based on the α gel film structure covering When Q 2, the ratio of the amount of heat obtained from the area of the endothermic peak based on the excess of α gel against heat obtained from the area of the whole endothermic peak Q 1 From the viewpoint of viscosity stability, / Q 0 is preferably 0.7 or less, more preferably 0.2 or less, and even more preferably 0.1 or less. The calories Q 0 , Q 1 , and Q 2 obtained from the area of the endothermic peak are obtained as follows. That is, a DDSC curve which is a differential value of the obtained DSC curve is created, and the temperature at which the slope starts to occur in the DDSC curve is used as the base point. The peak area can be obtained by connecting the base points to the DSC curve (baseline). The area of the entire endothermic peak (cm 2 ) included in the temperature range of 58 ° C to 68 ° C is A 0 , the area of the endothermic peak based on the excess α gel (cm 2 ) is A 1 , and the α gel film covering the emulsified droplets. Assuming that the area of the endothermic peak (cm 2 ) based on the structure is A 2 , the calories Q 0 , Q 1 , and Q 2 are expressed by the following equations.
Figure JPOXMLDOC01-appb-I000001
Here, mi is the sample amount (g), c is the feed rate of recorded data (cm / s), and P is the value of how many joules the vertical axis 1 cm of the DSC curve corresponds to in 1 second (J / cm ·. s).

 αゲル膜構造におけるαゲル膜の膜厚は、粘度安定性及び乳化安定性の観点から、5~20nmが好ましく、5~10nmであることがより好ましい。本明細書において、αゲル膜の膜厚は、電子顕微鏡観察により測定される乳化滴100個のαゲル膜の膜厚の平均値を意味する。 The film thickness of the α-gel film in the α-gel film structure is preferably 5 to 20 nm, more preferably 5 to 10 nm, from the viewpoint of viscosity stability and emulsion stability. In the present specification, the film thickness of the α-gel film means the average value of the film thickness of the α-gel film of 100 emulsified droplets measured by electron microscope observation.

 本発明の水中油型乳化組成物は、化粧料、医薬部外品、医薬品等として利用することができ、その形態は化粧水、美容液、スプレー剤原液、毛髪保護料、リキッドファンデーション等のメーキャップ製剤等液状のものである。本明細書において液状とは、実施例に記載の方法によって測定された粘度が100mPa・s以下であり、好ましくは50~0mPa・sであることを意味する。 The oil-in-water emulsified composition of the present invention can be used as cosmetics, quasi-drugs, pharmaceuticals, etc., and its forms are makeups such as cosmetics, beauty essences, undiluted sprays, hair protectants, and liquid foundations. It is a liquid product such as a preparation. As used herein, the term "liquid" means that the viscosity measured by the method described in Examples is 100 mPa · s or less, preferably 50 to 0 mPa · s.

 次に実施例等を挙げ、本発明を更に詳しく説明するが、本発明はこれら実施例等により何ら制約されるものではない。 Next, examples and the like will be given to explain the present invention in more detail, but the present invention is not restricted by these examples and the like.

試験例1:乳化滴の粒径による構造変化及び安定性
 下記の処方及び製法により平均乳化粒径80nm,110nm,170nm,1μmの水中油型組成物を調製した。得られた各組成物について下記条件によるDSC測定を行った。また平均乳化粒径80nm,110nmの組成物について、下記方法によりX線回折を行った。さらに平均乳化粒径110nmの組成物について、下記方法により電子顕微鏡観察を行った。結果を図1~3に示す。
Test Example 1: Structural change and stability depending on the particle size of the emulsified droplet An oil-in-water composition having an average emulsified particle size of 80 nm, 110 nm, 170 nm and 1 μm was prepared by the following formulation and production method. DSC measurement was performed on each of the obtained compositions under the following conditions. Further, the compositions having an average emulsified particle size of 80 nm and 110 nm were subjected to X-ray diffraction by the following method. Further, the composition having an average emulsified particle size of 110 nm was observed with an electron microscope by the following method. The results are shown in FIGS.

(処方)
(成分)                         (%)
1.ジメチコン(25℃ 6mPa・s)          5.0
2.セチルアルコール                   1.5
3.N-ステアロイル-N-メチルタウリンナトリウム    1.0
4.1,3-ブチレングリコール             12.0
5.メチルパラベン                    0.15
6.フェノキシエタノール                 0.15
7.精製水                       80.2
(Prescription)
(Ingredient) (%)
1. 1. Dimethicone (25 ° C, 6 mPa · s) 5.0
2. 2. Cetyl alcohol 1.5
3. 3. Sodium N-stearoyl-N-methyltaurine 1.0
4.1,3-butylene glycol 12.0
5. Methylparaben 0.15
6. Phenoxyethanol 0.15
7. Purified water 80.2

(製法)
A:No.1~3を均一に加熱混合溶解した。
B:No.4~7を均一に加熱混合溶解した。
C:BにAを添加し、乳化混合した後冷却した。
D-1:Cについてマイクロフルイダイザーによる高圧分散処理(圧力130MPa)を2回行って、平均乳化粒径80nmの水中油型乳化組成物を調製した。
D-2:Cについてマイクロフルイダイザーによる高圧分散処理(圧力100MPa)を3回行って、平均乳化粒径110nmの水中油型乳化組成物を調製した。
D-3:Cについてマイクロフルイダイザーによる高圧分散処理(圧力80MPa)を2回行って、平均乳化粒径170nmの水中油型乳化組成物を調製した。
D-4:Cについてデスパーにより2000rpmにて撹拌を行い、平均乳化粒径1μmの水中油型乳化組成物を調製した。
(Manufacturing method)
A: No. 1 to 3 were uniformly heated, mixed and dissolved.
B: No. 4 to 7 were uniformly heated, mixed and dissolved.
C: A was added to B, emulsified and mixed, and then cooled.
High-pressure dispersion treatment (pressure 130 MPa) with a microfluidizer was performed twice for D-1: C to prepare an oil-in-water emulsified composition having an average emulsified particle size of 80 nm.
D-2: C was subjected to high-pressure dispersion treatment (pressure 100 MPa) three times with a microfluidizer to prepare an oil-in-water emulsified composition having an average emulsified particle size of 110 nm.
High-pressure dispersion treatment (pressure 80 MPa) with a microfluidizer was carried out twice for D-3: C to prepare an oil-in-water emulsified composition having an average emulsified particle size of 170 nm.
D-4: C was stirred with Desper at 2000 rpm to prepare an oil-in-water emulsified composition having an average emulsified particle size of 1 μm.

(平均乳化粒径測定方法)
測定原理 動的散乱法
溶媒 水
測定温度 20℃ 
測定装置 リアルタイム ナノ粒子径測定装置 DelsaMax CORE
光源 100 mW DPSS 単一縦モードレーザー
レーザー波長 658 nm
検出器 粒子径測定 アバランシェフォトダイオード(APD)
検出器角度 粒子径測定 90°
粒径算出方法 マルチタウ方式よる自己相関係数を算出し、粒径を計算
(DSC測定方法)
 使用機器;EXSTAR DSC6200(セイコーインスツル社製)
 リファレンス;AIR
 上昇温度速度;5Cel/min,
 パン;P/N SSC000E031 AL15-CAPSULE
 解析ソフトウェア;EXSTAR6000 熱分析・レオロジーシステム (セイコーインスツル社製)
(Method of measuring average emulsified particle size)
Measurement principle Dynamic scattering method Solvent water Measurement temperature 20 ℃
Measuring device Real-time nanoparticle size measuring device DelsaMax CORE
Light Source 100 mW DPSS Single Longitudinal Mode Laser Laser Wavelength 658 nm
Detector particle size measurement avalanche photodiode (APD)
Detector angle Particle size measurement 90 °
Particle size calculation method Calculate the autocorrelation coefficient by the multi-tau method and calculate the particle size (DSC measurement method)
Equipment used; EXSTAR DSC6200 (manufactured by Seiko Instruments Inc.)
Reference; AIR
Rising temperature rate; 5 Cel / min,
Bread; P / N SSC000E031 AL15-CAPSULE
Analysis software; EXSTAR6000 Thermal analysis / rheology system (manufactured by Seiko Instruments Inc.)

(X線回折方法)
 測定機器;SAXSess(AntonPaar社製)
 測定条件;25℃、20min
(X-ray diffraction method)
Measuring equipment; SAXSess (manufactured by Anton Paar)
Measurement conditions; 25 ℃, 20min

 図1に示すとおり、平均乳化粒径1μmの組成物では、61℃付近に余剰のαゲルによる吸熱ピークが認められた。このピークは乳化滴の粒径が小さくなるにしたがって縮小するが、平均乳化粒径110nmの組成物では、このピークに加え58℃付近に乳化滴を被覆するαゲル膜構造に基づくピークが認められた。平均乳化粒径80nmの組成物では、61℃付近のピークは消失し、58℃付近のピークのみとなった。このことから平均乳化粒径1μm~170nmでは、αゲルは主に余剰のαゲルとして連続相中に分散しているが、110nmでは乳化滴を被覆するαゲルと余剰のαゲルが併存した状態となり、80nmになるとαゲルは主として乳化滴を被覆するものとして存在することが示唆された。平均乳化粒径110nm,80nmの組成物において、乳化滴を被覆するαゲル膜構造が形成されていることは、X線回折において15nm-1にピークが存在すること(図2)及び電子顕微鏡写真(図3)からも裏付けられる。 As shown in FIG. 1, in the composition having an average emulsified particle size of 1 μm, an endothermic peak due to excess α-gel was observed around 61 ° C. This peak shrinks as the particle size of the emulsified droplet becomes smaller, but in the composition having an average emulsified particle size of 110 nm, in addition to this peak, a peak based on the α gel film structure covering the emulsified droplet is observed at around 58 ° C. It was. In the composition having an average emulsified particle size of 80 nm, the peak around 61 ° C. disappeared and only the peak around 58 ° C. was left. From this, at an average emulsified particle size of 1 μm to 170 nm, the α-gel is mainly dispersed as a surplus α-gel in the continuous phase, but at 110 nm, the α-gel covering the emulsified droplet and the surplus α-gel coexist. At 80 nm, it was suggested that the α-gel mainly exists as a coating for emulsified droplets. In the composition having an average emulsified particle size of 110 nm and 80 nm, the formation of an α-gel film structure covering the emulsified droplets means that a peak exists at 15 nm -1 in X-ray diffraction (Fig. 2) and an electron micrograph. This is also supported by (Fig. 3).

 図1に基づき、吸熱ピーク全体の面積から求められる熱量Q、余剰のαゲルに基づく吸熱ピークの面積から求められる熱量Q及び乳化滴を被覆するαゲル膜構造に基づく吸熱ピークの面積から求められる熱量Qを上記解析ソフトウェアEXSTAR6000を用いて求め、吸熱ピーク全体の面積から求められる熱量に対する余剰のαゲルに基づく吸熱ピークの面積から求められる熱量の割合Q/Qを算出した。結果を表1に示す。 Based on FIG. 1, the amount of heat Q 0 obtained from the total area of the endothermic peak, the amount of heat Q 1 obtained from the area of the endothermic peak based on the surplus α gel, and the area of the endothermic peak based on the α gel film structure covering the emulsified droplets. the quantity of heat Q 2 to which sought to calculate the analysis software determined using EXSTAR6000, ratio Q 1 / Q 0 of the amount of heat obtained from the area of the endothermic peak based on the excess of α gel against heat obtained from the area of the whole endothermic peaks. The results are shown in Table 1.

Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002

各組成物について、製造直後及び50℃1ヶ月保存後の粘度及び乳化状態を下記測定方法及び判定基準に従って評価した。結果を表2に示す。 For each composition, the viscosity and emulsified state immediately after production and after storage at 50 ° C. for 1 month were evaluated according to the following measuring methods and criteria. The results are shown in Table 2.

(性状(粘度)の測定・評価方法)
 製造直後及び50℃で1か月保管した後、25℃における各試料の粘度を測定し、下記判定基準に従って評価した。粘度は、ブルックフィールド型粘度計を用いた化粧品原料基準・粘度測定法第二法に従って測定した。
(判定):(測定結果)
  ◎:10mPa・s以下
  〇:10mPa・sを超え100mPa・s以下
  ×:100mPa・sを超える
(Measurement / evaluation method of properties (viscosity))
Immediately after production and after storage at 50 ° C. for 1 month, the viscosity of each sample at 25 ° C. was measured and evaluated according to the following criteria. The viscosity was measured according to the cosmetic raw material standard / viscosity measurement method 2 using a Brookfield type viscometer.
(Judgment): (Measurement result)
⊚: 10 mPa · s or less 〇: More than 10 mPa · s and 100 mPa · s or less ×: More than 100 mPa · s

(性状(乳化状態)の評価方法)
 各試料について、製造直後及び50℃で1か月保管した後の乳化状態を目視により確認し、下記判定基準にしたがって評価した。
(判定):(状態)
  〇:クリーミング、分離が認められない
  △:分離は認められないが、クリーミングが認められる
  ×:分離が認められる
(Evaluation method of properties (emulsification state))
For each sample, the emulsified state immediately after production and after storage at 50 ° C. for 1 month was visually confirmed and evaluated according to the following criteria.
(Judgment): (Status)
〇: Creaming and separation are not observed Δ: Separation is not observed, but creaming is observed ×: Separation is observed

Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003

 表1及び2より、平均乳化粒径が170nmであり、割合Q/Qが0.783である試験例に比べて、平均乳化粒径が110nmであり、割合Q/Qが0.136である試験例および平均乳化粒径が80nmであり、割合Q/Qが0である試験例が、50℃1ヶ月保存後も増粘することなく100mPa・s以下の粘度を維持しており、経時的な粘度安定性に優れることが確認された。 From Tables 1 and 2, the average emulsified particle size is 110 nm and the ratio Q 1 / Q 0 is 0, as compared with the test example in which the average emulsified particle size is 170 nm and the ratio Q 1 / Q 0 is 0.783. The test example having a viscosity of 136 and the test example having an average emulsified particle size of 80 nm and a ratio of Q 1 / Q 0 of 0 maintained a viscosity of 100 mPa · s or less without thickening even after storage at 50 ° C. for 1 month. It was confirmed that the viscosity stability over time was excellent.

参考例1:リポソーム含有化粧水の調製
 下記に示す組成の化粧水を下記製造方法により調製した。得られた化粧水について、電子顕微鏡観察を行った。電子顕微鏡写真を図4に示す。
Reference Example 1: Preparation of liposome-containing lotion The lotion having the composition shown below was prepared by the following production method. The obtained lotion was observed with an electron microscope. An electron micrograph is shown in FIG.

参考例1:化粧水
(成分)                         (%)
1.リン脂質                       1.0
2.キサンタンガム                     0.1
3.カルボキシビニルポリマー               0.05
4.1,3-ブチレングリコール             20.0
5.グリセリン                      4.5
6.水酸化ナトリウム                   0.02
7.パラオキシ安息香酸エステル              0.1
8.香料                         微 量
9.精製水                        残 量
Reference example 1: Toner (ingredient) (%)
1. 1. Phospholipid 1.0
2. 2. Xanthan gum 0.1
3. 3. Carboxyvinyl polymer 0.05
4.1,3-butylene glycol 20.0
5. Glycerin 4.5
6. Sodium hydroxide 0.02
7. Paraoxybenzoic acid ester 0.1
8. Fragrance amount 9. Residual amount of purified water

(製造方法)
A:No.1、8、及び9の一部をリポソーム化した。
B:残りの成分をすべて混合した。
C:AとBを混合し、化粧水を得た。
(Production method)
A: No. Part of 1, 8 and 9 were liposomalized.
B: All the remaining components were mixed.
C: A and B were mixed to obtain a lotion.

 図3における本発明のαゲル膜構造を有する乳化滴は内部に油相を有するのに対し、図4におけるリポソームは、内部に油相を有さず、明らかに相違する。また、リポソームはマルチラメラ膜を形成しているため、複数の層状に膜構造が存在していることが見て取れるが、本発明のαゲル膜構造は層状の膜構造が観察されず、ラメラ膜数が少ないことが分かる。
また、本発明のαゲル膜の厚さは、炭素数16以上の直鎖飽和高級アルコールが、おおよそ3分子分であること(αゲル膜が高級アルコール3分子膜であること)が分かる。αゲル膜構造をとるためには、他には5分子膜、7分子膜、9分子膜等となることも考えられるが、その場合、膜数の増加によりネットワーク構造が形成され、増粘する可能性がある。したがって、αゲル膜の膜厚は、粘度安定性及び乳化安定性の観点から、5~20nmが好ましく、5~10nmであることがより好ましく、炭素数16以上の直鎖飽和高級アルコールが、おおよそ3分子分であること(αゲル膜が高級アルコール3分子膜であること)がさらに好ましい。
The emulsified droplet having the α-gel membrane structure of the present invention in FIG. 3 has an oil phase inside, whereas the liposome in FIG. 4 does not have an oil phase inside, which is clearly different. Further, since the liposome forms a multi-lamellar membrane, it can be seen that the membrane structure exists in a plurality of layers, but the α-gel membrane structure of the present invention does not have a layered membrane structure, and the number of lamellar membranes is not observed. It turns out that there are few.
Further, it can be seen that the thickness of the α-gel film of the present invention is about 3 molecules of the linear saturated higher alcohol having 16 or more carbon atoms (the α-gel film is a higher alcohol trimolecular film). In order to adopt the α-gel film structure, it is possible to use a 5-layer film, a 7-layer film, a 9-layer film, etc., but in that case, a network structure is formed by increasing the number of films, and the thickness increases. there is a possibility. Therefore, the thickness of the α-gel film is preferably 5 to 20 nm, more preferably 5 to 10 nm from the viewpoint of viscosity stability and emulsion stability, and a linear saturated higher alcohol having 16 or more carbon atoms is approximately used. It is more preferable that the amount is 3 molecules (the α-gel film is a higher alcohol tri-molecule film).

実施例1~14及び比較例1~12
 下記表3~6に示す組成の化粧水を下記製造方法により調製した。得られた化粧水について、製造直後及び50℃1ヶ月保存後の粘度及び乳化状態を下記測定方法及び判定基準に従って評価した。また乳化滴を被覆するαゲル膜構造の存在について、下記方法により評価した。結果を併せて表3~6に示す。なお、表3~6の組成中の数値は%を意味する。
Examples 1 to 14 and Comparative Examples 1 to 12
Toners having the compositions shown in Tables 3 to 6 below were prepared by the following production methods. The obtained lotion was evaluated for its viscosity and emulsified state immediately after production and after storage at 50 ° C. for 1 month according to the following measuring method and criteria. The existence of the α-gel membrane structure covering the emulsified droplet was evaluated by the following method. The results are also shown in Tables 3-6. The numerical values in the compositions of Tables 3 to 6 mean%.

Figure JPOXMLDOC01-appb-T000004
*1 ニッコールSMT(日光ケミカルズ社製)
*2 アミソフトHA-P(香栄興業社製)
*3 ニッコールDDP-8(日光ケミカルズ社製)
Figure JPOXMLDOC01-appb-T000004
* 1 Nikkor SMT (manufactured by Nikko Chemicals)
* 2 Amisoft HA-P (manufactured by Koei Kogyo Co., Ltd.)
* 3 Nikkor DDP-8 (manufactured by Nikko Chemicals)

Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005

Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006

Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007

<製造方法>
(実施例1、7、8、10)
A:No.1~15を均一に加熱混合溶解した。
B:No.16~19を均一に加熱混合溶解した。
C:BにAを添加し、乳化混合した。
D:Cを冷却し、マイクロフルイダイザーによる高圧分散処理(圧力200MPa)を2回行い、化粧水を得た。
<Manufacturing method>
(Examples 1, 7, 8, 10)
A: No. 1 to 15 were uniformly heated, mixed and dissolved.
B: No. 16 to 19 were uniformly heated, mixed and dissolved.
C: A was added to B and emulsified and mixed.
D: C was cooled, and high-pressure dispersion treatment (pressure 200 MPa) was performed twice with a microfluidizer to obtain a lotion.

(実施例2、11~14)
A:No.1~15を均一に加熱混合溶解した。
B:No.16~19を均一に加熱混合溶解した。
C:BにAを添加し、乳化混合した。
D:Cを冷却し、マイクロフルイダイザーによる高圧分散処理(圧力200MPa)を1回行い、化粧水を得た。
(Examples 2, 11-14)
A: No. 1 to 15 were uniformly heated, mixed and dissolved.
B: No. 16 to 19 were uniformly heated, mixed and dissolved.
C: A was added to B and emulsified and mixed.
D: C was cooled, and high-pressure dispersion treatment (pressure 200 MPa) was performed once with a microfluidizer to obtain a lotion.

(実施例3~6、9、比較例1~12)
A:No.1~15を均一に加熱混合溶解した。
B:No.16~19を均一に加熱混合溶解した。
C:BにAを添加し、乳化混合した。
D:Cを冷却し、マイクロフルイダイザーによる高圧分散処理(圧力100MPa)を2回行い、化粧水を得た。
(Examples 3 to 6, 9 and Comparative Examples 1 to 12)
A: No. 1 to 15 were uniformly heated, mixed and dissolved.
B: No. 16 to 19 were uniformly heated, mixed and dissolved.
C: A was added to B and emulsified and mixed.
D: C was cooled, and high-pressure dispersion treatment (pressure 100 MPa) was performed twice with a microfluidizer to obtain a lotion.

<評価方法>
(乳化滴を被覆するαゲル膜構造の存在)
 各化粧水について、下記条件によるDSC測定により吸熱ピークを観察し、以下の基準にしたがって判定した。
 [DSC条件]
 使用機器;EXSTAR DSC6200(セイコーインスツル社製)
 リファレンス;AIR
 上昇温度速度;5Cel/min,
 パン;P/N SSC000E031 AL15-CAPSULE
 [判定基準]
(判定):(状態)
  ◎:58℃付近のみに1つのピークが観察された
  〇:58℃付近、61℃付近にそれぞれ2つのピークが観察された
  △:61℃付近のみに1つのピークが観察された
  ×:ピークが観察されなかった
  -:測定不可であった
<Evaluation method>
(Existence of α-gel membrane structure covering emulsified droplets)
For each lotion, the endothermic peak was observed by DSC measurement under the following conditions, and the determination was made according to the following criteria.
[DSC conditions]
Equipment used; EXSTAR DSC6200 (manufactured by Seiko Instruments Inc.)
Reference; AIR
Rising temperature rate; 5 Cel / min,
Bread; P / N SSC000E031 AL15-CAPSULE
[Criteria]
(Judgment): (Status)
⊚: One peak was observed only around 58 ° C 〇: Two peaks were observed around 58 ℃ and 61 ℃ respectively Δ: One peak was observed only around 61 ℃ ×: Peak was observed Not observed-: Not measurable

 上記DSC測定により◎又は〇と判定された試料について、電顕顕微鏡観察により、αゲル膜構造が乳化滴を被覆する様子が観察された(図3参照;図中の丸で囲った部分)。さらにX線回折(測定機器;SAXSess(AntonPaar社製)、測定条件;25℃、20min)を行ったところ、15nm-1にαゲル膜構造に由来するピークが認められた(図2参照)。 With respect to the sample judged to be ⊚ or 〇 by the DSC measurement, it was observed that the α-gel film structure covered the emulsified droplets by electron microscopic observation (see FIG. 3; circled part in the figure). Further, X-ray diffraction (measuring instrument; SAXSess (manufactured by AntonPaar), measuring conditions; 25 ° C., 20 min) was performed, and a peak derived from the α gel film structure was observed at 15 nm -1 (see FIG. 2).

(性状(粘度)の測定・評価方法)
 製造直後及び50℃で1か月保管した後、25℃における各試料の粘度を測定し、下記判定基準に従って評価した。粘度は、ブルックフィールド型粘度計を用いた化粧品原料基準・粘度測定法第二法に従って測定した。
(判定):(測定結果)
  ◎:10mPa・s以下
  〇:10mPa・sを超え100mPa・s以下
  ×:100mPa・sを超える
(Measurement / evaluation method of properties (viscosity))
Immediately after production and after storage at 50 ° C. for 1 month, the viscosity of each sample at 25 ° C. was measured and evaluated according to the following criteria. The viscosity was measured according to the cosmetic raw material standard / viscosity measurement method 2 using a Brookfield type viscometer.
(Judgment): (Measurement result)
⊚: 10 mPa · s or less 〇: More than 10 mPa · s and 100 mPa · s or less ×: More than 100 mPa · s

(性状(乳化状態)の評価方法)
 各試料について、製造直後及び50℃で1か月保管した後の乳化状態を目視により確認し、下記判定基準にしたがって評価した。
(判定):(状態)
  〇:クリーミング、分離が認められない
  △:分離は認められないが、クリーミングが認められる
  ×:分離が認められる
(Evaluation method of properties (emulsification state))
For each sample, the emulsified state immediately after production and after storage at 50 ° C. for 1 month was visually confirmed and evaluated according to the following criteria.
(Judgment): (Status)
〇: Creaming and separation are not observed Δ: Separation is not observed, but creaming is observed ×: Separation is observed

 表3及び4に示すとおり、実施例1~14の化粧水はいずれも、乳化滴を被覆するαゲル膜構造の存在が認められ、製造直後から液状を呈し、50℃1ヶ月保存後も増粘することなく100mPa・s以下の粘度を維持していた。また分離やクリーミングが生じることもなく、良好な乳化状態を保持していた。これに対し、平均乳化粒径170nm以上の比較例1~2の化粧水は、αゲル膜構造の存在が確認されず、経時的な粘度上昇が認められた。また成分(A)炭素数16以上の直鎖飽和高級アルコールに代えて、分岐のあるものや炭素数が16未満のものを使用した比較例3~5の化粧水は、いずれも製造直後から分離が認められた(初期分離)。成分(B)に代えてノニオン性界面活性剤を使用した場合も同様に初期分離が生じ(比較例6)、カチオン性界面活性剤や成分(B)以外のアニオン性界面活性剤を用いた場合には、αゲル膜構造の存在が確認されず、平均乳化粒径を160nm以下としても、50℃1ヶ月保存後に分離したり、経時的に粘度が上昇するなど乳化安定性及び粘度安定性に劣るものとなった(比較例11,12)。また成分(A)及び(B)の合計に対する成分(C)の含有質量比が0.3~0.75の範囲外にある場合にも、同様に乳化安定性や粘度安定性に劣るものとなった(比較例7~10)。 As shown in Tables 3 and 4, the lotions of Examples 1 to 14 all showed the presence of an α-gel film structure covering the emulsified droplets, became liquid immediately after production, and increased even after storage at 50 ° C. for 1 month. It maintained a viscosity of 100 mPa · s or less without sticking. In addition, no separation or creaming occurred, and a good emulsified state was maintained. On the other hand, in the lotions of Comparative Examples 1 and 2 having an average emulsified particle size of 170 nm or more, the existence of the α-gel film structure was not confirmed, and the viscosity increased with time. Further, the lotions of Comparative Examples 3 to 5 in which the component (A) a linear saturated higher alcohol having 16 or more carbon atoms was replaced with a branched one or one having less than 16 carbon atoms were separated immediately after production. Was observed (initial separation). Similarly, when a nonionic surfactant is used instead of the component (B), initial separation occurs (Comparative Example 6), and when a cationic surfactant or an anionic surfactant other than the component (B) is used. The existence of the α-gel film structure was not confirmed in the product, and even if the average emulsified particle size was 160 nm or less, the emulsion stability and viscosity stability were improved by separating after storage at 50 ° C. for 1 month and increasing the viscosity over time. It became inferior (Comparative Examples 11 and 12). Further, even when the content mass ratio of the component (C) to the total of the components (A) and (B) is outside the range of 0.3 to 0.75, the emulsion stability and the viscosity stability are similarly inferior. (Comparative examples 7 to 10).

試験例2:油溶性有効成分の安定性試験
 下記表7に示す組成の化粧水を下記製造方法により調製した。得られた化粧水について、下記の方法により油溶性有効成分の安定性を評価した。
Test Example 2: Stability test of oil-soluble active ingredient A lotion having the composition shown in Table 7 below was prepared by the following production method. The stability of the oil-soluble active ingredient of the obtained lotion was evaluated by the following method.

Figure JPOXMLDOC01-appb-T000008
*4 アスタキサンチン―5C(オリザ油化社製)
*5 β-カロチン(三共製薬)
*6 カネカ・コエンザイムQ10(カネカ)
Figure JPOXMLDOC01-appb-T000008
* 4 Astaxanthin-5C (manufactured by Oriza Yuka Co., Ltd.)
* 5 β-carotene (Sankyo Pharmaceutical Co., Ltd.)
* 6 Kaneka Coenzyme Q10 (Kaneka)

(製造方法)
A:No.1~8を均一に加熱混合溶解した。
B:No.9~12を均一に加熱混合溶解した。
C:BにAを添加し、乳化混合した。
D:Cを冷却し、マイクロフルイダイザーによる高圧分散処理(圧力130MPa)を2回行って、化粧水を得た。
(Production method)
A: No. 1 to 8 were uniformly heated, mixed and dissolved.
B: No. 9 to 12 were uniformly heated, mixed and dissolved.
C: A was added to B and emulsified and mixed.
D: C was cooled, and high-pressure dispersion treatment (pressure 130 MPa) was performed twice with a microfluidizer to obtain a lotion.

(アスタキサンチン、β-カロチンおよびユビデカレノンの安定性評価方法)
 各化粧水について製造直後及び50℃で1か月保管した後の吸光度を測定した。分光光度計UV-2500PC UV-VIS REDCORDING SPECTROPHOTOMETER(SHIMADZU社製)を用い、光路長10mm×光路幅10mmのガラスセルにて、リファレンスには精製水を使用し、アスタキサンチンにおいては波長480nm付近、β-カロチンにおいては波長450nm付近、ユビデカレノンにおいては280nm付近で吸光度を測定した。吸光度残存率を下記式により算出し、下記基準に従ってアスタキサンチン、β-カロチン、ユビデカレノンの安定性を評価した。
 吸光度残存率(%)=(50℃で1か月保管した後の試料の吸光度)
                ×100/(製造直後の試料の吸光度)
(Stability evaluation method for astaxanthin, β-carotene and ubidecalenone)
The absorbance of each lotion was measured immediately after production and after storage at 50 ° C. for 1 month. Using a spectrophotometer UV-2500PC UV-VIS REDCORDING SPECTROPHOTOMETER (manufactured by SHIMADZU), a glass cell with an optical path length of 10 mm and an optical path width of 10 mm, using purified water as a reference, and for astaxanthin, a wavelength of around 480 nm, β- Absorbance was measured at a wavelength of around 450 nm for carotene and at around 280 nm for ubidecalenone. The residual absorbance was calculated by the following formula, and the stability of astaxanthin, β-carotene, and ubidecalenone was evaluated according to the following criteria.
Residual absorbance (%) = (absorbance of sample after storage at 50 ° C for 1 month)
× 100 / (absorbance of sample immediately after production)

<安定性判定基準>
(判定):(吸光度残存率)
  ◎:吸光度残存率が60%以上
  〇:吸光度残存率が50%以上60%未満
  ×:吸光度残存率が50%未満
<Stability criteria>
(Judgment): (Residual absorbance)
⊚: Absorbance residual rate is 60% or more 〇: Absorbance residual rate is 50% or more and less than 60% ×: Absorbance residual rate is less than 50%

 表7に示すとおり、実施例15の化粧水では、比較例13と比較して50℃1ヶ月保存後におけるアスタキサンチンの退色が明らかに抑制された。これは、実施例15ではαゲル膜構造が乳化滴を被覆して、乳化滴界面がより強固となるため、アスタキサンチンのオストワルドライプニングに伴う水等への接触が抑制され、その結果アスタキサンチンの分解等が抑制されるのに対し、比較例13の化粧水では乳化滴の周囲にαゲル膜構造が形成されないため、アスタキサンチンの水等への接触とそれに伴う分解等が生じるためと考えられる。β-カロチン及びユビデカレノンについても同様に、50℃1ヶ月保存後でも安定して維持されることが確認された。 As shown in Table 7, in the lotion of Example 15, the fading of astaxanthin after storage at 50 ° C. for 1 month was clearly suppressed as compared with Comparative Example 13. This is because, in Example 15, the α-gel membrane structure covers the emulsified droplets and the emulsified droplet interface becomes stronger, so that the contact of astaxanthin with water or the like associated with the ostwald drying is suppressed, and as a result, the decomposition of astaxanthin is suppressed. However, in the cosmetic solution of Comparative Example 13, the α-gel film structure is not formed around the emulsified droplets, so that it is considered that contact of astaxanthin with water and the like and accompanying decomposition occur. Similarly, it was confirmed that β-carotene and ubidecalenone were stably maintained even after storage at 50 ° C. for 1 month.

試験例3:非極性油に対する極性油の比と安定性
 下記表8に示す組成の化粧水を下記製造方法により調製した。得られた化粧水について、実施例1~14と同様にして製造直後及び50℃1カ月保存後の粘度及び乳化状態を評価した。またアスタキサンチンの安定性について試験例2と同様にして評価した。結果を表6に併せて示す。
Test Example 3: Ratio and stability of polar oil to non-polar oil A lotion having the composition shown in Table 8 below was prepared by the following production method. The obtained lotion was evaluated for its viscosity and emulsified state immediately after production and after storage at 50 ° C. for 1 month in the same manner as in Examples 1 to 14. The stability of astaxanthin was evaluated in the same manner as in Test Example 2. The results are also shown in Table 6.

Figure JPOXMLDOC01-appb-T000009
*7 ハイコールK-230(カネダ)
*8 Myritol GTEH(BASF)
Figure JPOXMLDOC01-appb-T000009
* 7 HYCOAL K-230 (Kaneda)
* 8 Myritol GTEH (BASF)

(製造方法)
A:No.1~5を均一に加熱混合溶解した。
B:No.6~9を均一に加熱混合溶解した。
C:BにAを添加し、乳化混合した。
D:Cを冷却し、マイクロフルイダイザーによる高圧分散処理(圧力130MPa)を2回行って、化粧水を得た。
(Production method)
A: No. 1 to 5 were uniformly heated, mixed and dissolved.
B: No. 6 to 9 were uniformly heated, mixed and dissolved.
C: A was added to B and emulsified and mixed.
D: C was cooled, and high-pressure dispersion treatment (pressure 130 MPa) was performed twice with a microfluidizer to obtain a lotion.

 表8に示すとおり、実施例19~21および実施例25の化粧水は、実施例27の化粧水と比較して50℃1ヶ月保存後における粘度安定性および乳化安定性がより良好であった。さらに、実施例22~24および実施例26の化粧水は、実施例28の化粧水と比較して50℃1ヶ月保存後における粘度安定性、乳化安定性および油溶性有効成分の安定性がより良好であった。これは、非極性油に対する極性油の含有質量割合((極性油)/(非極性油))は、低いほど、直鎖飽和高級アルコールとの相溶性が下がり、αゲル膜構造の高温経時安定性が良好になるためと考えられる。 As shown in Table 8, the cosmetics of Examples 19 to 21 and 25 had better viscosity stability and emulsion stability after storage at 50 ° C. for 1 month than those of Example 27. .. Furthermore, the lotions of Examples 22 to 24 and 26 have higher viscosity stability, emulsion stability and oil-soluble active ingredient stability after storage at 50 ° C. for 1 month than those of Example 28. It was good. This is because the lower the mass ratio of polar oil to non-polar oil ((polar oil) / (non-polar oil)), the lower the compatibility with linear saturated higher alcohol, and the stability of the α-gel film structure over time at high temperature. This is thought to be due to the improved polarity.

実施例27:化粧水
(成分)                         (%)
1.ジメチコン(25℃ 6mPa・s)          4.5
2.パルミチン酸エチルヘキシル*9              0.5
3.セトステアリルアルコール               1.5
4.ベヘニルアルコール                  0.8
5.セトステアリルアルコール               0.8
6.N-ステアロイル-N-メチルタウリンナトリウム    0.7
7.グリセリン                      1.0
8.1,3-ブチレングリコール             12.0
9.トリプロピレングリコール               0.5
10.クエン酸                      0.01
11.クエン酸Na                    0.01
12.精製水                       残量
*9 サラコス P-8(日清オイリオグループ社製)
(製造方法)
A:No.1~5を均一に加熱混合溶解した。
B:No.6~12を均一に加熱混合溶解した。
C:BにAを添加し、乳化混合した。
D:Cを冷却し、マイクロフルイダイザーによる高圧分散処理(圧力130MPa)を2回行って、化粧水を得た。
Example 27: Toner (ingredient) (%)
1. 1. Dimethicone (25 ° C 6 mPa · s) 4.5
2. 2. Ethylhexyl palmitate * 9 0.5
3. 3. Setostearyl alcohol 1.5
4. Behenyl alcohol 0.8
5. Setostearyl alcohol 0.8
6. Sodium N-stearoyl-N-methyltaurine 0.7
7. Glycerin 1.0
8.1,3-butylene glycol 12.0
9. Tripropylene glycol 0.5
10. Citric acid 0.01
11. Na citrate 0.01
12. Remaining amount of purified water
* 9 Sarakos P-8 (manufactured by Nisshin Oillio Group)
(Production method)
A: No. 1 to 5 were uniformly heated, mixed and dissolved.
B: No. 6 to 12 were uniformly heated, mixed and dissolved.
C: A was added to B and emulsified and mixed.
D: C was cooled, and high-pressure dispersion treatment (pressure 130 MPa) was performed twice with a microfluidizer to obtain a lotion.

 以上のようにして得られた実施例27の化粧水は、製造直後は30mPa・sの液状であり、平均乳化粒径が80nmで乳化状態も良好であった。50℃、1ヶ月経過時点の粘度安定性、乳化安定性も良好であった。 The lotion of Example 27 obtained as described above was a liquid of 30 mPa · s immediately after production, had an average emulsified particle size of 80 nm, and was in a good emulsified state. Viscosity stability and emulsification stability at 50 ° C. after 1 month were also good.

 本発明の水中油型乳化組成物は、液状でありながら経時的な粘度安定性及び乳化安定性に優れるものであるため、液状の化粧料や医薬部外品等に利用することができる。 The oil-in-water emulsified composition of the present invention is liquid but has excellent viscosity stability and emulsification stability over time, and therefore can be used for liquid cosmetics, quasi-drugs, and the like.

Claims (6)

 次の成分(A)~(C);
 (A)炭素数16以上の直鎖飽和高級アルコール
 (B)N-ステアロイル-N-メチルタウリンナトリウム並びにN
   -ステアロイル-L-グルタミン酸及びその塩よりなる群から
   選択される1種以上のアニオン性界面活性剤
 (C)液状油
 を含有し、成分(B)に対する成分(A)の含有モル比(A/B)が2.8~6、成分(C)に対する成分(A)及び(B)の合計の含有質量比((A+B)/C)が0.3~0.75であって、平均乳化粒径が160nm以下である液状水中油型組成物。
The following components (A) to (C);
(A) Linear saturated higher alcohol having 16 or more carbon atoms (B) N-stearoyl-N-methyltaurine sodium and N
It contains one or more anionic surfactants (C) liquid oil selected from the group consisting of -stearoyl-L-glutamic acid and salts thereof, and the content molar ratio (A /) of the component (A) to the component (B). B) is 2.8 to 6, the total mass ratio ((A + B) / C) of the components (A) and (B) to the component (C) is 0.3 to 0.75, and the average emulsified granules. A liquid oil-in-water composition having a diameter of 160 nm or less.
 25℃における粘度が100mPa・s以下である請求項1に記載の液状水中油型組成物。 The liquid oil-in-water composition according to claim 1, which has a viscosity at 25 ° C. of 100 mPa · s or less.  成分(C)液状油が、ミネラルオイル及びジメチコンよりなる群から選択される1種又は2種である請求項1または2に記載の液状水中油型組成物。 The liquid oil-in-water composition according to claim 1 or 2, wherein the liquid oil component (C) is one or two selected from the group consisting of mineral oil and dimethicone.  成分(C)液状油における非極性油に対する極性油の含有質量割合((極性油)/(非極性油)が0.5以下である請求項1~3のいずれかの項記載の液状水中油型組成物。 Component (C) The liquid water oil according to any one of claims 1 to 3, wherein the content mass ratio of the polar oil to the non-polar oil in the liquid oil ((polar oil) / (non-polar oil) is 0.5 or less). Mold composition.  さらに成分(D)油溶性有効成分を含有する請求項1~4のいずれかの項に記載の液状水中油型組成物。 The liquid oil-in-water composition according to any one of claims 1 to 4, further containing the component (D) oil-soluble active ingredient.  示差走査熱量計により測定されるDSC曲線において、58~68℃の温度範囲に含まれる吸熱ピーク全体の面積から求められる熱量に対する余剰のαゲルに基づく吸熱ピークの面積から求められる熱量の割合が0.7以下である請求項1~5のいずれかの項に記載の液状水中油型組成物。 In the DSC curve measured by the differential scanning calorimeter, the ratio of the amount of heat obtained from the area of the endothermic peak based on the surplus α gel to the amount of heat obtained from the area of the entire endothermic peak included in the temperature range of 58 to 68 ° C is 0. The liquid oil-in-water composition according to any one of claims 1 to 5, which is 7. or less.
PCT/JP2020/019369 2019-05-17 2020-05-15 Liquid oil-in-water composition Ceased WO2020235459A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020217037463A KR20220009958A (en) 2019-05-17 2020-05-15 Liquid oil-in-water composition
JP2021520756A JP7585198B2 (en) 2019-05-17 2020-05-15 Liquid oil-in-water compositions
CN202080036679.3A CN113811283B (en) 2019-05-17 2020-05-15 Liquid oil-in-water composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-093361 2019-05-17
JP2019093361 2019-05-17

Publications (1)

Publication Number Publication Date
WO2020235459A1 true WO2020235459A1 (en) 2020-11-26

Family

ID=73458213

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/019369 Ceased WO2020235459A1 (en) 2019-05-17 2020-05-15 Liquid oil-in-water composition

Country Status (5)

Country Link
JP (1) JP7585198B2 (en)
KR (1) KR20220009958A (en)
CN (1) CN113811283B (en)
TW (1) TWI880930B (en)
WO (1) WO2020235459A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06271421A (en) * 1993-03-15 1994-09-27 Shiseido Co Ltd Oil-in-water emulsion composition
JPH09301847A (en) * 1996-03-15 1997-11-25 Shiseido Co Ltd Low viscosity water in oil-type emulsified composition and dermal agent for external use using the same
JP2002012517A (en) * 2000-04-27 2002-01-15 Kao Corp Emulsified cosmetic
JP2010006716A (en) * 2008-06-24 2010-01-14 Fancl Corp alpha GEL-CONTAINING COMPOSITION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3829048B2 (en) 2000-06-05 2006-10-04 株式会社資生堂 Oil-in-water emulsion composition
WO2015190306A1 (en) 2014-06-13 2015-12-17 株式会社 資生堂 α-GEL-INTERMEDIATE COMPOSITION, AND PRODUCTION METHOD FOR α-GEL-CONTAINING O/W EMULSION COSMETIC USING SAID COMPOSITION

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06271421A (en) * 1993-03-15 1994-09-27 Shiseido Co Ltd Oil-in-water emulsion composition
JPH09301847A (en) * 1996-03-15 1997-11-25 Shiseido Co Ltd Low viscosity water in oil-type emulsified composition and dermal agent for external use using the same
JP2002012517A (en) * 2000-04-27 2002-01-15 Kao Corp Emulsified cosmetic
JP2010006716A (en) * 2008-06-24 2010-01-14 Fancl Corp alpha GEL-CONTAINING COMPOSITION

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
INOUE, HARUHIKO: "Formulation technology of vitamin A derivatives", FRAGRANCE JOURNAL, vol. 6, 2004, pages 21 - 26 *
OKAMAOTO, TOHRU: "Preparation Technique for Nanoemulsions and Their Application for Cosmetics", OLEOSCIENCE, vol. 7, no. 3, 2007, pages 105 - 110 *
SUZUKI, TOSHIYUKI ET AL.: "Secondary Droplets Formed in 0/W Emulsion- Formation Mechanism and Effects of Their Formation on the Properties of Emulsion", NIPPON KAGAKU KAISHI, vol. 3, 1983, pages 337 - 344, XP055762821 *

Also Published As

Publication number Publication date
KR20220009958A (en) 2022-01-25
JPWO2020235459A1 (en) 2020-11-26
CN113811283B (en) 2025-01-28
TWI880930B (en) 2025-04-21
CN113811283A (en) 2021-12-17
TW202110419A (en) 2021-03-16
JP7585198B2 (en) 2024-11-18

Similar Documents

Publication Publication Date Title
EP3003491B1 (en) Cosmetic compositions comprising an associative polyurethane and a hydrophobic coated pigment
JP5393123B2 (en) External preparation for skin and method for producing the same
JP6364322B2 (en) Cosmetic or skin preparation
US20190038528A1 (en) Nano-emulsion cosmetic composition in which high content oils are stabilized
US20200352844A1 (en) Composition with luminous satin effect comprising particles of cellulose, of boron nitride and of satin nacres
EP2617410B1 (en) Oil-in-water type cosmetic
JP5689639B2 (en) Oil-in-water emulsified cosmetic
JP5662774B2 (en) Emulsified composition
JP5662794B2 (en) Water-in-oil emulsion composition
JP6133618B2 (en) Water-in-oil emulsion composition
CA2984120C (en) Cosmetic nanoemulsion
JP6542099B2 (en) Oil-in-water skin external preparation
JP5825768B2 (en) Oil-in-water emulsified cosmetic
JP5869296B2 (en) Water-in-oil emulsion composition
KR20240128886A (en) Water-based emulsified cosmetic composition
JP7585198B2 (en) Liquid oil-in-water compositions
JP2010132621A (en) Water-in-oil type emulsified cosmetic
JP2024095622A (en) Emulsion particle refining agent, emulsion stability improver, method for improving emulsion stability of emulsion, method for producing emulsion, and emulsion
KR102556501B1 (en) A cosmetic composition comprising natural polymers
HK40064836B (en) Liquid oil-in-water composition
HK40064836A (en) Liquid oil-in-water composition
JP5824323B2 (en) Water-in-oil emulsion composition
JP2013091620A (en) Water-in-oil type emulsion composition
JP2010132620A (en) Water-in-oil type emulsified cosmetic
JP2021155371A (en) Oil-in-water type emulsion composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20810223

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021520756

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20810223

Country of ref document: EP

Kind code of ref document: A1

WWG Wipo information: grant in national office

Ref document number: 202080036679.3

Country of ref document: CN